WO2024117203A1 - Photocurable composition, three-dimensional shaped article, dental product, and splint - Google Patents
Photocurable composition, three-dimensional shaped article, dental product, and splint Download PDFInfo
- Publication number
- WO2024117203A1 WO2024117203A1 PCT/JP2023/042813 JP2023042813W WO2024117203A1 WO 2024117203 A1 WO2024117203 A1 WO 2024117203A1 JP 2023042813 W JP2023042813 W JP 2023042813W WO 2024117203 A1 WO2024117203 A1 WO 2024117203A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- meth
- photocurable composition
- acrylic monomer
- mass
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/15—Compositions characterised by their physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
- A61K6/887—Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/46—Polymerisation initiated by wave energy or particle radiation
- C08F2/48—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
- C08F2/50—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
- C08F290/02—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated end groups
- C08F290/06—Polymers provided for in subclass C08G
Definitions
- This disclosure relates to photocurable compositions, three-dimensional objects, dental products, and splints.
- dental products such as dental prostheses and instruments used in the oral cavity have been studied.
- a method of manufacturing three-dimensional objects such as dental products by stereolithography using a 3D printer is known (for example, Patent No. 4160311).
- Dental products for example, dental splints
- dental splints are primarily used by being worn in the oral cavity, and are subject to wear due to repeated biting caused by teeth grinding or the like.
- a strong load is applied to the teeth, which may cause pain to the wearer, and may place a large burden on the wearer.
- the problem that one embodiment of the present disclosure aims to solve is to provide a photocurable composition that can be used to produce a three-dimensional object that is resistant to wear due to teeth grinding and the like and reduces the burden on the wearer when worn in the oral cavity, as well as to provide such a three-dimensional object, a dental product, and a splint.
- a photocurable composition comprising a photopolymerizable component and a photopolymerization initiator, the photocurable composition being irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/ cm2 to form a cured layer A1 of 50 ⁇ m in thickness, the cured layer A1 being laminated in the thickness direction to form a rectangular plate-shaped object A1 of length 40 mm, width 10 mm and thickness 1 mm, and the shaped object A1 being irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 to produce a rectangular plate-shaped test piece A1 of length 40 mm, width 10 mm and thickness 1 mm, the photocurable composition having a storage modulus at 37° C.
- ⁇ E * ab of the test piece A2 is 10.0 or less.
- the photopolymerizable component includes: a (meth)acrylic monomer (A) containing two (meth)acryloyloxy groups and having a molecular weight of 1,000 or more; a (meth)acrylic monomer (B) containing two (meth)acryloyloxy groups and having a molecular weight of 170 or more and less than 1,000; and a (meth)acrylic monomer (C) containing one (meth)acryloyloxy group and having an aromatic ring structure.
- ⁇ 4> The photocurable composition according to ⁇ 3>, wherein the (meth)acrylic monomer (A) further contains a urethane bond.
- ⁇ 5> The photocurable composition according to ⁇ 3> or ⁇ 4>, wherein the (meth)acrylic monomer (C) has a molecular weight of 140 to 500.
- ⁇ 6> The photocurable composition according to any one of ⁇ 3> to ⁇ 5>, wherein the content of the (meth)acrylic monomer (A) is 5% by mass to 60% by mass based on the total amount of the (meth)acrylic monomer components.
- ⁇ 7> The photocurable composition according to any one of ⁇ 3> to ⁇ 6>, wherein the content of the (meth)acrylic monomer (B) is 15% by mass to 80% by mass based on the total amount of the (meth)acrylic monomer components.
- ⁇ 8> The photocurable composition according to any one of ⁇ 3> to ⁇ 7>, wherein the content of the (meth)acrylic monomer (C) is 5% by mass to 70% by mass based on the total amount of the (meth)acrylic monomer components.
- ⁇ 9> The photocurable composition according to any one of ⁇ 3> to ⁇ 8>, in which the content (mol/g) of methacryloyl groups relative to the total content (mol/g) of acryloyl groups and methacryloyl groups in the photopolymerizable component is 0% to 90%.
- ⁇ 10> The photocurable composition according to any one of ⁇ 1> to ⁇ 9>, wherein the photopolymerization initiator contains an acylphosphine oxide compound.
- ⁇ 11> The photocurable composition according to any one of ⁇ 1> to ⁇ 10>, which has a viscosity of 5 mPa ⁇ s to 6,000 mPa ⁇ s as measured with an E-type viscometer at 25° C.
- ⁇ 12> The photocurable composition according to any one of ⁇ 1> to ⁇ 11>, which is a photocurable composition for stereolithography.
- ⁇ 13> The photocurable composition according to any one of ⁇ 1> to ⁇ 12>, which is used for producing a splint by stereolithography.
- ⁇ 14> A three-dimensional object comprising a cured product of the photocurable composition according to any one of ⁇ 1> to ⁇ 13>.
- ⁇ 15> A dental product comprising the three-dimensional object according to ⁇ 14>.
- ⁇ 16> A splint including the three-dimensional object according to ⁇ 14>.
- a photocurable composition capable of producing a three-dimensional object that is resistant to wear due to teeth grinding and the like and reduces the burden on the wearer when worn in the oral cavity, as well as such a three-dimensional object, a dental product, and a splint.
- a numerical range expressed using “to” means a range that includes the numerical values before and after “to” as the lower and upper limits.
- the term “process” refers not only to an independent process, but also to a process that cannot be clearly distinguished from other processes, as long as the intended purpose of the process is achieved.
- the amount of each component contained in the composition means the total amount of the plurality of substances present in the composition, unless otherwise specified.
- the upper or lower limit value described in one numerical range may be replaced with the upper or lower limit value of another numerical range described in stages.
- the upper or lower limit value of the numerical range may be replaced with a value shown in the examples.
- the term "light” is a concept that encompasses active energy rays such as ultraviolet light and visible light.
- (meth)acrylate means acrylate or methacrylate
- (meth)acryloyl means acryloyl or methacryloyl
- (meth)acrylic means acrylic or methacrylic
- the photocurable composition of the present disclosure is a photocurable composition containing a photopolymerizable component and a photopolymerization initiator, and the photocurable composition is irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/cm2 to form a cured layer A1 of a thickness of 50 ⁇ m, and the cured layer A1 is laminated in the thickness direction to form a rectangular plate-shaped object A1 of length 40 mm, width 10 mm, and thickness 1 mm.
- the object A1 is irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 to produce a rectangular plate-shaped test piece A1 of length 40 mm, width 10 mm, and thickness 1 mm.
- the storage modulus of the test piece A1 at 37° C. is 100 MPa or more and 1500 MPa or less.
- the photocurable composition disclosed herein by containing the above-mentioned components, can produce a three-dimensional object that is resistant to wear due to teeth grinding and the like, and reduces the burden on the wearer when worn in the oral cavity.
- liquid tank type stereolithography that is, stereolithography using a liquid tank
- a portion of the photocurable composition i.e., an uncured photocurable composition in a liquid state; the same applies below
- Liquid tank type stereolithography differs from inkjet type stereolithography in that a liquid tank is used.
- the liquid vat type stereolithography is broadly divided into DLP (Digital Light Processing) type stereolithography and SLA (Stereolithography) type stereolithography.
- DLP type Digital Light Processing
- SLA Stepolithography
- a light beam is irradiated onto a photocurable composition in a liquid vat in a planar manner.
- SLA type a laser beam is scanned onto a photocurable composition in a liquid vat.
- a build table that is vertically movable; a tray (i.e., a liquid tank) that is disposed below the build table (on the side in the direction of gravity; the same applies below), includes a light-transmitting portion, and contains a photocurable composition; a light source (e.g., an LED light source) disposed below the tray for irradiating the photocurable composition in the tray with planar light through a light-transmitting portion of the tray;
- a 3D printer equipped with the above function e.g., "Cara Print 4.0" manufactured by Kulzer, "Max UV” manufactured by Asiga, etc.
- a gap of one layer is provided between the build table and the tray, and the gap is filled with the photocurable composition.
- the photocurable composition filled in the gap is irradiated with planar light from below through the light-transmitting portion of the tray, and the area irradiated with light is cured to form a first cured layer.
- the gap between the build table and the tray is widened by the next layer, and the resulting space is filled with the photocurable composition.
- the photocurable composition filled in the space is irradiated with light in the same manner as the curing of the first layer, and a second cured layer is formed.
- the cured layers are stacked to produce a three-dimensional object.
- the three-dimensional object produced may be further cured by further irradiating the three-dimensional object with light.
- the photocurable composition of the present disclosure is irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/ cm2 to form a cured layer A1 of a thickness of 50 ⁇ m, and the cured layer A1 is laminated in the thickness direction to form a rectangular plate-shaped object A1 of length 40 mm, width 10 mm and thickness 1 mm.
- the shaped object A1 is irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 to produce a rectangular plate-shaped test piece A1 of length 40 mm, width 10 mm and thickness 1 mm.
- the storage modulus of the test piece A1 at 37° C. is 100 MPa or more and 1500 MPa or less.
- the storage modulus at 37°C is preferably 150 MPa or more, more preferably 200 MPa or more, even more preferably 300 MPa or more, and particularly preferably 400 MPa or more, from the viewpoint of resistance to wear due to teeth grinding, etc.
- the storage modulus at 37°C is preferably 1400 MPa or less, more preferably 1200 MPa or less, even more preferably 1000 MPa or less, and particularly preferably 800 MPa or less, from the viewpoint of reducing the burden on the wearer when the device is worn in the oral cavity.
- Test piece A1 is a rectangular plate-shaped test piece having a length of 40 mm, a width of 10 mm, and a thickness of 1 mm.
- Test piece A1 was produced by photopolymerization under the following conditions: the photocurable composition of the present disclosure was irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/ cm2 to form a cured layer A1 with a thickness of 50 ⁇ m, the cured layer A1 was then stacked in the thickness direction to form a rectangular plate-shaped object A1 with a length of 40 mm, a width of 10 mm and a thickness of 1 mm, and the object A1 was then irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 .
- the test piece A1 can be produced, for example, according to an example of the DLP type stereolithography described above.
- the test piece A1 may be produced using a
- the storage modulus at 37° C. is, in particular, the storage modulus at 37° C. measured by dynamic viscoelasticity measurement under conditions of a temperature rise range of 25° C. to 300° C. at a temperature rise rate of 3° C./min at a measurement frequency of 1 Hz.
- a dynamic viscoelasticity measuring device a dynamic viscoelasticity measuring device "DMA7100" manufactured by Hitachi High-Tech Corporation may be used.
- the photocurable composition of the present disclosure is irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/ cm2 to form a cured layer A2 of a thickness of 50 ⁇ m, and the cured layer A2 is laminated in the thickness direction to form a rectangular plate-shaped object A2 of a length of 50 mm, a width of 40 mm, and a thickness of 4.5 mm.
- the object A2 is then irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 , and the 50 mm x 40 mm surfaces are then double-polished to produce a rectangular plate-shaped test piece A2 of a length of 50 mm, a width of 40 mm, and a thickness of 4.0 mm.
- the ⁇ E * ab of test piece A2 is 10.0 or less.
- ⁇ E * ab is more preferably 6.0 or less, further preferably 5.5 or less, particularly preferably 5.0 or less, and most preferably 4.5 MPa or less.
- the lower limit of ⁇ E * ab there is no particular restriction on the lower limit of ⁇ E * ab , and it may be more than 0, 0.1 or more, or 1.0 or more. When the requirement for transparency of the cured product is low, the lower limit of ⁇ E * ab may be more than 6.0.
- Test piece A2 is a rectangular plate-shaped test piece having a length of 50 mm, a width of 40 mm, and a thickness of 4.0 mm.
- Test piece A2 was produced by irradiating the photocurable composition of the present disclosure with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/ cm2 to form a cured layer A2 with a thickness of 50 ⁇ m, stacking the cured layer A2 in the thickness direction to form a rectangular plate-shaped object A2 with a length of 50 mm, a width of 40 mm, and a thickness of 4.5 mm, irradiating object A2 with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 , and then polishing both sides of the 50 mm x 40 mm surfaces.
- the test piece A2 can be produced, for example, according to an example of the DLP type stereolithography described above.
- the test piece A2 may be
- ⁇ E * ab is measured by a color difference meter in transmission mode for the L * a * b * of a 50mm x 40mm surface, using the attached STANDARD WHITE PLATE (SCI X: 94.25, Y: 99.44, Z: 106.37) as a reference.
- As the color difference meter SD3000 manufactured by Nippon Denshoku Industries Co., Ltd. may be used.
- the photocurable compositions of the present disclosure contain at least one photopolymerizable component.
- the photopolymerizable component includes a compound containing an ethylenic double bond.
- Examples of the compound containing an ethylenic double bond include (meth)acrylic monomers, styrene, styrene derivatives, and (meth)acrylonitrile.
- the photopolymerizable component As the photopolymerizable component, the photopolymerizable components described in paragraphs 0030 to 0059 of WO 2019/189652 may be used.
- the content of the photopolymerizable component in the total amount of the photocurable composition of the present disclosure is preferably 60% by mass or more, more preferably 80% by mass or more, and even more preferably 90% by mass or more.
- the photopolymerizable component preferably contains at least one (meth)acrylic monomer.
- the (meth)acrylic monomer means a monomer having one or more (meth)acryloyl groups.
- the (meth)acrylic monomer a monomer having one or more (meth)acryloyloxy groups is preferable.
- all (meth)acrylic monomers contained in the photocurable composition may be referred to as "(meth)acrylic monomer components," and the total content of all (meth)acrylic monomers contained in the photocurable composition of this disclosure may be referred to as “total amount of (meth)acrylic monomer components.”
- the total amount of (meth)acrylic monomer components relative to the total amount of photopolymerizable components in the photocurable composition of the present disclosure is preferably 80% by mass or more, more preferably 90% by mass or more, and even more preferably 95% by mass or more.
- the total amount of (meth)acrylic monomer components relative to the total amount of the photocurable composition of the present disclosure is preferably 60% by mass or more, more preferably 80% by mass or more, and even more preferably 90% by mass or more.
- the (meth)acrylic monomer constituting the (meth)acrylic monomer component is not particularly limited as long as it is a monomer having one or more (meth)acryloyl groups.
- the (meth)acrylic monomer is It may be a mono(meth)acrylic monomer having one (meth)acryloyl group (hereinafter also referred to as a "monofunctional (meth)acrylic monomer”); It may be a di(meth)acrylic monomer having two (meth)acryloyl groups (hereinafter also referred to as a "bifunctional (meth)acrylic monomer”); It may be a poly(meth)acrylic monomer having three or more (meth)acryloyl groups (hereinafter also referred to as a "polyfunctional (meth)acrylic monomer”).
- the mono(meth)acrylic monomer is preferably a mono(meth)acrylic monomer having one (meth)acryloyloxy group.
- the di(meth)acrylic monomer is preferably a di(meth)acrylic monomer having two (meth)acryloyloxy groups.
- the tri(meth)acrylic monomer is preferably a poly(meth)acrylic monomer having three or more (meth)acryloyloxy groups.
- the photopolymerizable component is A (meth)acrylic monomer (A) containing two (meth)acryloyloxy groups and having a molecular weight of 1,000 or more; (B) a (meth)acrylic monomer containing two (meth)acryloyloxy groups and having a molecular weight of 170 or more and less than 1,000; and (C) a (meth)acrylic monomer containing one (meth)acryloyloxy group and containing an aromatic ring structure It is preferable to include at least one of the following:
- the photopolymerizable component is A (meth)acrylic monomer (A) containing two (meth)acryloyloxy groups and having a molecular weight of 1000 or more; a (meth)acrylic monomer (B) containing two (meth)acryloyloxy groups and having a molecular weight of 170 or more and less than 1,000; A (meth)acrylic monomer (C) containing one (meth)acryloyloxy group and containing an aromatic ring structure; It is more preferred that the composition comprises: When these conditions are satisfied, the storage modulus at 37° C. can be easily adjusted to fall within the above range.
- the (meth)acrylic monomer (A) contains two (meth)acryloyloxy groups and has a molecular weight of 1,000 or more.
- the photopolymerizable component contains the (meth)acrylic monomer (A)
- the softness of the obtained cured product can be improved (i.e., the storage modulus at 37°C can be adjusted to be lowered), and the reactivity is also excellent.
- the molecular weight of the (meth)acrylic monomer (A) is 1,000 or more, preferably 1,300 or more, more preferably 1,700 or more, and even more preferably 2,100 or more. There is no particular upper limit to the molecular weight of the (meth)acrylic monomer (A).
- the molecular weight of the (meth)acrylic monomer (A) may be 20,000 or less, preferably 10,000 or less, more preferably 8,000 or less, and even more preferably 6,000 or less.
- the molecular weight of the (meth)acrylic monomer (A) is preferably 1,000 or more and 15,000 or less, and more preferably 1,000 or more and 10,000 or less.
- the (meth)acrylic monomer (A) preferably contains a urethane bond. That is, the (meth)acrylic monomer (A) is preferably a urethane diacrylate monomer. This provides the resulting cured product with excellent toughness.
- the (meth)acrylic monomer (A) is preferably a compound represented by the following general formula (A1):
- R 1 's are each independently a divalent organic group
- R 2 's are each independently a divalent hydrocarbon group which may have a substituent
- R 3 's are each independently a hydrogen atom or a methyl group
- X is a divalent organic group
- n is an integer of 0 to 10.
- examples of R 1 include divalent organic groups containing one or more bonds selected from the group consisting of divalent hydrocarbon groups, ether bonds, and ester bonds.
- the divalent hydrocarbon group represented by R 1 may be, for example, a divalent chain hydrocarbon group or a divalent hydrocarbon group containing a ring structure (aromatic ring structure, alicyclic structure).
- the number of the ether bonds is preferably 1 to 30, more preferably 1 to 20, and further preferably 1 to 15.
- the divalent organic group represented by R 1 contains an ester bond
- the number of the ester bonds is preferably 1 to 12, more preferably 1 to 8, and further preferably 1 to 6.
- R 1 may have, for example, 2 to 60 carbon atoms, preferably 2 to 40 carbon atoms, and more preferably 2 to 30 carbon atoms.
- R 1 is preferably a group represented by the following general formula (A1-R 1 ).
- R 1A is a divalent hydrocarbon group which may have a substituent
- R 1C is a divalent hydrocarbon group
- m is an integer of 0 to 10.
- * indicates a bonding position.
- the divalent hydrocarbon group which may have a substituent as R 1A in general formula (A1-R 1 ) is, for example, a divalent chain hydrocarbon group or a divalent hydrocarbon group containing a ring structure, preferably a divalent chain hydrocarbon group.
- the ring structure contained in the divalent hydrocarbon group may be an aromatic structure or an alicyclic structure.
- the divalent chain hydrocarbon group represented by R 1A may be branched and may be saturated or unsaturated.
- the divalent chain hydrocarbon group represented by R 1A preferably has 2 to 20 carbon atoms, more preferably 2 to 15 carbon atoms, and even more preferably 2 to 10 carbon atoms.
- the substituent that the divalent chain hydrocarbon group represented by R 1A may have is, for example, an alkoxy group having 2 to 10 carbon atoms or an aryloxy group having 6 to 20 carbon atoms, preferably an aryloxy group.
- the aryloxy group include a phenoxy group and a naphthyloxy group, and the phenoxy group is preferred.
- the divalent hydrocarbon group containing an aromatic structure represented by R 1A is preferably a divalent hydrocarbon group having an aromatic structure containing 6 to 25 carbon atoms (more preferably 6 to 20 carbon atoms, and even more preferably 6 to 15 carbon atoms).
- Examples of the substituent that the divalent hydrocarbon group containing an aromatic structure may have include a linear or branched alkyl group having 1 to 6 carbon atoms.
- the divalent hydrocarbon group containing an alicyclic structure represented by R 1A is preferably a divalent hydrocarbon group having an alicyclic structure having 3 to 20 carbon atoms (more preferably 6 to 12 carbon atoms, and even more preferably 6 to 8 carbon atoms).
- Examples of the substituent that the divalent hydrocarbon group containing an alicyclic structure may have include a linear or branched alkyl group having 1 to 6 carbon atoms.
- Examples of the divalent hydrocarbon group represented by R 1C in general formula (A1-R 1 ) include divalent chain hydrocarbon groups and divalent hydrocarbon groups containing a ring structure (aromatic structure or alicyclic structure), with a divalent chain hydrocarbon group being preferred.
- the divalent chain hydrocarbon group represented by R 1C preferably has 1 to 30 carbon atoms, more preferably 1 to 20 carbon atoms, and even more preferably 1 to 10 carbon atoms.
- the divalent hydrocarbon group having an aromatic structure represented by R 1C is preferably a divalent hydrocarbon group having an aromatic structure having 6 to 25 carbon atoms (more preferably 6 to 20 carbon atoms, and even more preferably 6 to 15 carbon atoms).
- the divalent hydrocarbon group containing an alicyclic structure as R 1C is preferably a divalent hydrocarbon group having an alicyclic structure having 3 to 20 carbon atoms (more preferably 6 to 12 carbon atoms, and even more preferably 6 to 8 carbon atoms).
- m is an integer of 0 to 10, preferably 0 to 8, and more preferably 0 to 6.
- the * on the left side i.e., the bonding position from R 1A
- the * on the right side i.e., the bonding position from R 1C
- the * on the right side i.e., the bonding position from R 1C
- the divalent hydrocarbon group represented by R 2 is, for example, a divalent chain hydrocarbon group or a divalent hydrocarbon group containing a ring structure.
- the divalent chain hydrocarbon group represented by R2 preferably has 1 to 25 carbon atoms, more preferably has 1 to 20 carbon atoms, and even more preferably has 2 to 15 carbon atoms.
- the divalent hydrocarbon group containing a ring structure represented by R2 may contain an aromatic structure or an alicyclic structure.
- the divalent hydrocarbon group containing an aromatic structure represented by R2 preferably has 6 to 25 carbon atoms, more preferably 6 to 20 carbon atoms, and even more preferably 6 to 15 carbon atoms.
- the divalent hydrocarbon group containing an alicyclic structure represented by R2 preferably has 3 to 20 carbon atoms, more preferably 6 to 15 carbon atoms, and even more preferably 6 to 10 carbon atoms.
- the divalent hydrocarbon group represented by R 2 is preferably a divalent hydrocarbon group represented by a structure selected from the following general formulae (A1-R 2 -1) to (A1-R 2 -13).
- X is a divalent organic group, and is preferably a divalent organic group containing one or more bonds selected from the group consisting of ether bonds and ester bonds.
- the divalent organic group represented by X contains an ether bond
- the number of the ether bonds is preferably 1 to 100, more preferably 2 to 90, and further preferably 4 to 80.
- the divalent organic group represented by X contains an ester bond
- the number of ester bonds is preferably 1 to 100, more preferably 2 to 90, and further preferably 4 to 80.
- the divalent organic group represented by X preferably has 2 to 500 carbon atoms, more preferably 2 to 400 carbon atoms, and even more preferably 2 to 300 carbon atoms.
- X is preferably a group represented by the following general formula (A1-X):
- R XA is a divalent hydrocarbon group
- R XC is a divalent hydrocarbon group
- k is an integer of 0 to 100.
- the divalent hydrocarbon group represented by R XA in general formula (A1-X) is, for example, a divalent chain hydrocarbon group or a divalent hydrocarbon group containing a ring structure, and is preferably a divalent chain hydrocarbon group.
- the ring structure contained in the divalent hydrocarbon group may be an aromatic structure or an alicyclic structure.
- the divalent chain hydrocarbon group represented by R 1 XA may be branched and may be saturated or unsaturated.
- the divalent chain hydrocarbon group represented by R 1 XA preferably has 2 to 20 carbon atoms, more preferably 2 to 15 carbon atoms, and even more preferably 2 to 10 carbon atoms.
- the divalent hydrocarbon group containing an aromatic structure as R XA is preferably a divalent hydrocarbon group having an aromatic structure having 6 to 25 carbon atoms (more preferably 6 to 20 carbon atoms, and even more preferably 6 to 15 carbon atoms).
- the divalent hydrocarbon group containing an alicyclic structure as R XA is preferably a divalent hydrocarbon group having an alicyclic structure having 3 to 20 carbon atoms (more preferably 6 to 12 carbon atoms, and even more preferably 6 to 8 carbon atoms).
- Examples of the divalent hydrocarbon group represented by R 3 XC in general formula (A1-X) include divalent chain hydrocarbon groups and divalent hydrocarbon groups containing a ring structure, with a divalent chain hydrocarbon group being preferred.
- the divalent chain hydrocarbon group represented by R 3 XC preferably has 1 to 30 carbon atoms, more preferably 1 to 20 carbon atoms, and even more preferably 1 to 10 carbon atoms.
- the divalent hydrocarbon group containing an aromatic structure as R XC is preferably a divalent hydrocarbon group having an aromatic structure having 6 to 25 carbon atoms (more preferably 6 to 20 carbon atoms, and even more preferably 6 to 15 carbon atoms).
- the divalent hydrocarbon group containing an alicyclic structure as R 3 XC is preferably a divalent hydrocarbon group having an alicyclic structure having 3 to 20 carbon atoms (more preferably 6 to 12 carbon atoms, and even more preferably 6 to 8 carbon atoms).
- k is 0 to 100, preferably 2 to 90, and more preferably 4 to 80.
- the content of (meth)acrylic monomer (A) is preferably 5% by mass to 60% by mass, more preferably 10% by mass to 50% by mass, and even more preferably 15% by mass to 45% by mass, based on the total amount of (meth)acrylic monomer components.
- the (meth)acrylic monomer (B) contains two (meth)acryloyloxy groups and has a molecular weight of 170 or more and less than 1,000.
- the photopolymerizable component contains the (meth)acrylic monomer (B)
- the hardness of the obtained cured product can be improved (i.e., the storage modulus at 37°C can be adjusted to be increased), and the reactivity is also excellent.
- the (meth)acrylic monomer (B) preferably contains a cyclic structure.
- the number of rings in the cyclic structure contained in the (meth)acrylic monomer (B) may be only one, or may be two or more.
- the cyclic structure contained in the (meth)acrylic monomer (B) may be either an aromatic ring structure or an alicyclic structure, or both, but preferably contains an aromatic ring structure.
- the cyclic structure contained in the (meth)acrylic monomer (B) is particularly preferably a bisphenol A structure.
- the (meth)acrylic monomer (B) contains two urethane bonds, and for example, a compound represented by the following general formula (B1) (hereinafter also referred to as "(meth)acrylic monomer (B1)”) is preferable.
- R1 is independently a divalent organic group
- R2 is independently a divalent hydrocarbon group which may have a substituent
- R3 is independently a hydrogen atom or a methyl group.
- a plurality of R1s and R3s may be the same or different.
- R 1 examples include divalent organic groups containing one or more bonds selected from the group consisting of divalent hydrocarbon groups and ether bonds.
- the divalent hydrocarbon group represented by R 1 is preferably, for example, a divalent chain hydrocarbon group or a divalent hydrocarbon group containing a ring structure (aromatic ring structure, alicyclic structure).
- the number of the ether bonds is more preferably 1 to 2.
- R 1 may have, for example, 2 to 30 carbon atoms, preferably 2 to 20 carbon atoms, and more preferably 2 to 10 carbon atoms.
- R 1 is preferably an alkylene group having 2 to 6 carbon atoms which may have a substituent, and the substituent is preferably an aryloxy group (for example, a phenoxy group).
- the photocurable composition of the present disclosure contains the (meth)acrylic monomer (B1) as the (meth)acrylic monomer (B), the (meth)acrylic monomer (B) may further contain a (meth)acrylic monomer (B2) having neither a urethane bond nor a ring structure.
- the molecular weight of the (meth)acrylic monomer (B) is 170 or more and less than 1,000, preferably 200 or more and 800 or less, and more preferably 300 or more and 700 or less.
- (Meth)acrylic monomers (B) include ethoxylated bisphenol A diacrylate, urethane di(meth)acrylate, tetraethylene glycol diacrylate, nonanepropylene glycol dimethacrylate, etc.
- (meth)acrylic monomers (B2) include tetraethylene glycol diacrylate, nonanepropylene glycol dimethacrylate, propoxylated (2) neopentyl glycol diacrylate, etc.
- the content of the (meth)acrylic monomer (B) is preferably 15% by mass to 80% by mass, more preferably 20% by mass to 70% by mass, and even more preferably 25% by mass to 60% by mass, based on the total amount of the (meth)acrylic monomer components.
- the content of the (meth)acrylic monomer (B1) is preferably 10% by mass to 60% by mass, more preferably 15% by mass to 50% by mass, and even more preferably 20% by mass to 45% by mass, relative to the total amount of the (meth)acrylic monomer components
- the content of the (meth)acrylic monomer (B2) is preferably 0.1% by mass to 20% by mass, more preferably 1% by mass to 20% by mass, and even more preferably 1.5% by mass to 10% by mass, relative to the total amount of the (meth)acrylic monomer components.
- the (meth)acrylic monomer (C) contains one (meth)acryloyloxy group and contains an aromatic ring structure.
- the softness of the obtained cured product can be improved (i.e., the storage modulus at 37° C. can be adjusted to be lower), and excessive reactivity can be suppressed.
- the (meth)acrylic monomer (C) may also be used as a diluent.
- the (meth)acrylic monomer (C) has an aromatic ring structure.
- the number of aromatic ring structures contained in the (meth)acrylic monomer (C) may be only one, or may be two or more.
- the aromatic ring structure contained in the (meth)acrylic monomer (C) is particularly preferably a benzene ring.
- the molecular weight of the (meth)acrylic monomer (C) is preferably 140-500, more preferably 150-400, and even more preferably 170-300.
- the (meth)acrylic monomer (C) may be, for example, a compound represented by the following formula (C1):
- R 1 is a monovalent organic group having an aromatic ring
- R 2 is a hydrogen atom or a methyl group.
- R 1 preferably has 6 to 30 carbon atoms, and more preferably has 6 to 20 carbon atoms.
- the monovalent organic group represented by R 1 in formula (C1) may have one or more aromatic rings, and preferably has one or two aromatic rings.
- the aromatic ring contained in the monovalent organic group represented by R 1 in formula (C1) may be a monocyclic ring or a polycyclic ring.
- Examples of the monocyclic aromatic ring include a phenyl structure (phenyl group, phenylene group).
- the monocyclic aromatic ring may have a substituent, and examples of the substituent include an alkyl group, an aryloxy group (e.g., a phenoxy group), an arylalkylene group, and an aryl group.
- Examples of the polycyclic aromatic ring include a naphthyl structure (a naphthyl group, a naphthylene group).
- the polycyclic aromatic ring may have a substituent, and examples of the substituent include an alkyl group, an aryloxy group (such as a phenoxy group), an arylalkylene group, and an aryl group.
- R 1 is preferably a monovalent organic group represented by a structure selected from the following general formulae (C1-R 1 -1) to (C1-R 1 -7).
- R 1A represents an alkyl group having 1 to 10 carbon atoms.
- Examples of (meth)acrylic monomers (C) include benzyl methacrylate, phenoxyethyl methacrylate, phenoxyethyl acrylate, m-phenoxybenzyl acrylate, 2-(o-phenylphenoxy)ethyl acrylate, 2-hydroxy-3-phenoxypropyl acrylate, etc.
- the content of the (meth)acrylic monomer (C) is preferably 5% by mass to 70% by mass based on the total amount of the (meth)acrylic monomer components.
- the content of the (meth)acrylic monomer (C) is 70 mass% or less based on the total amount of the (meth)acrylic monomer components, the reactivity is excellent, and thus the moldability is excellent and an increase in viscosity can be suppressed.
- the content of the (meth)acrylic monomer (C) is more preferably 60% by mass or less, and even more preferably 50% by mass or less, based on the total amount of the (meth)acrylic monomer components.
- the content of the (meth)acrylic monomer (C) is 5 mass % or more based on the total amount of the (meth)acrylic monomer components, excessive reactivity can be suppressed. From the above viewpoint, the content of the (meth)acrylic monomer (C) is more preferably 10 mass % or more based on the total amount of the (meth)acrylic monomer components.
- the photopolymerizable component may contain a (meth)acrylic monomer other than the above-mentioned (meth)acrylic monomer (A), (meth)acrylic monomer (B), and (meth)acrylic monomer (C).
- the molecular weight of the other (meth)acrylic monomer is preferably 80 to 600, more preferably 100 to 400, and even more preferably 140 to 250.
- the other (meth)acrylic monomer a (meth)acrylic monomer having one (meth)acryloyloxy group is preferred.
- a (meth)acrylic monomer having no aromatic ring structure is also preferred.
- a (meth)acrylic monomer (D) containing one (meth)acryloyloxy group and having no aromatic ring structure is more preferable.
- the photopolymerizable component contains the (meth)acrylic monomer (D)
- an increase in the viscosity of the photocurable composition can be suppressed, and the viscosity of the photocurable composition can be easily adjusted.
- the effect of improving the softness of the resulting cured product can be obtained.
- the molecular weight of the (meth)acrylic monomer (D) is preferably 120 to 400, more preferably 1300 to 350, and even more preferably 140 to 300.
- the content of the (meth)acrylic monomer (D) is preferably 0% by mass to 30% by mass, more preferably 1% by mass to 30% by mass, more preferably 5% by mass to 25% by mass, and still more preferably 10% by mass to 23% by mass, based on the total amount of the (meth)acrylic monomer components.
- the content of the (meth)acrylic monomer (D) is 30% by mass or less (preferably 25% by mass or less) based on the total amount of the (meth)acrylic monomer components, the reactivity is excellent. This makes it possible to provide excellent moldability and suppress an increase in viscosity.
- the content of the (meth)acrylic monomer (D) is 5% by mass or more based on the total amount of the (meth)acrylic monomer components, an increase in viscosity can be suppressed and excessive reactivity can be suppressed.
- Examples of (meth)acrylic monomers (D) include tertiary butyl (meth)acrylate, cyclohexyl (meth)acrylate, isobornyl (meth)acrylate, and tetrahydrofurfuryl (meth)acrylate.
- the total content of (meth)acrylic monomer (A) and (meth)acrylic monomer (B) is preferably 20% by mass to 95% by mass with respect to the total amount of (meth)acrylic monomer components (i.e., the total content of all (meth)acrylic monomers contained in the photocurable composition).
- the total content of the (meth)acrylic monomer (A), the (meth)acrylic monomer (B), and the (meth)acrylic monomer (C) is preferably 50 mass% or more, more preferably 65 mass% or more, even more preferably 80 mass% or more, and particularly preferably 90 mass% or more, based on the total amount of the (meth)acrylic monomer components (i.e., the total content of all the (meth)acrylic monomers contained in the photocurable composition).
- the total content may be 100% by mass or less than 100% by mass (for example, 95% by mass or less, 90% by mass or less, etc.).
- the total content of the (meth)acrylic monomer (A), the (meth)acrylic monomer (B), the (meth)acrylic monomer (C) and the (meth)acrylic monomer (D) is preferably 60 mass% or more, more preferably 80 mass% or more, even more preferably 90 mass% or more, and particularly preferably 95 mass% or more, based on the total amount of the (meth)acrylic monomer components (i.e., the total content of all the (meth)acrylic monomers contained in the photocurable composition).
- the total content may be 100% by mass or less than 100% by mass (for example, 95% by mass or less, 90% by mass or less, etc.).
- the total content of the (meth)acrylic monomer (A), the (meth)acrylic monomer (B), the (meth)acrylic monomer (C) and the (meth)acrylic monomer (D) is preferably 60 mass% or more, more preferably 80 mass% or more, even more preferably 90 mass% or more, and particularly preferably 95 mass% or more, based on the total amount of the photopolymerizable components.
- the total content may be 100% by mass or less than 100% by mass (for example, 95% by mass or less, 90% by mass or less, etc.).
- the content (mol/g) of methacryloyl groups relative to the total content (mol/g) of acryloyl groups and methacryloyl groups is preferably 0% to 90%.
- the content (mol/g) of methacryloyl groups relative to the total content (mol/g) of acryloyl groups and methacryloyl groups is 90% or less, excellent reactivity and improved moldability are achieved.
- the content (mol/g) of methacryloyl groups relative to the total content (mol/g) of acryloyl groups and methacryloyl groups is more preferably 70% or less, even more preferably 50% or less, and particularly preferably 40% or less.
- the content (mol/g) of methacryloyl groups relative to the total content (mol/g) of acryloyl groups and methacryloyl groups is 0% or more (particularly, more than 0%), the hardness of the obtained cured product is excellent.
- the content (mol/g) of methacryloyl groups relative to the total content (mol/g) of acryloyl groups and methacryloyl groups is more preferably 3% or more, even more preferably 5% or more, and particularly preferably 10% or more.
- the photocurable composition of the present disclosure contains a photopolymerization initiator.
- the photopolymerization initiator include alkylphenone compounds, acylphosphine oxide compounds, titanocene compounds, oxime ester compounds, benzoin compounds, acetophenone compounds, benzophenone compounds, thioxanthone compounds, ⁇ -acyloxime ester compounds, phenylglyoxylate compounds, benzyl compounds, azo compounds, diphenyl sulfide compounds, iron-phthalocyanine compounds, benzoin ether compounds, and anthraquinone compounds.
- the photopolymerization initiator preferably contains at least one selected from the group consisting of alkylphenone compounds and acylphosphine oxide compounds. From the viewpoint of transparency of the obtained cured product (that is, keeping ⁇ E * ab low), it is preferable that the composition contains an acylphosphine oxide compound.
- the photopolymerization initiator is It is preferable to include an acylphosphine oxide compound (e.g., 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide, bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide, etc.), More preferably, it comprises 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide.
- an acylphosphine oxide compound e.g., 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide, bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide, etc.
- the amount of photopolymerization initiator contained in the photocurable composition of the present disclosure is preferably 0.1 parts by mass to 20 parts by mass, more preferably 0.2 parts by mass to 10 parts by mass, even more preferably 0.3 parts by mass to 5 parts by mass, and even more preferably 0.3 parts by mass to 3 parts by mass, per 100 parts by mass of the photopolymerizable component.
- the total content of the (meth)acrylic monomer component and the photopolymerization initiator contained in the photocurable composition of the present disclosure is preferably 50% by mass or more, more preferably 70% by mass or more, more preferably 80% by mass or more, more preferably 90% by mass or more, and more preferably 95% by mass or more, based on the total mass of the photocurable composition.
- the photocurable composition of the present disclosure may further contain at least one filler.
- the filler inorganic particles are preferred, and inorganic oxide particles are more preferred.
- the filler is more preferably at least one selected from the group consisting of silica particles (i.e., silicon oxide particles), zirconia particles (i.e., zirconium oxide particles), aluminosilicate particles, alumina particles (i.e., aluminum oxide particles), and titania particles (i.e., titanium oxide particles). It is particularly preferred that the filler comprises silica particles.
- the average particle size of the filler is not particularly limited, but from the viewpoint of making it easier to achieve the production of test piece A1 by light irradiation, it is preferably 5 nm to 500 nm, more preferably 5 nm to 200 nm, even more preferably 5 nm to 100 nm, and even more preferably 5 nm to 70 nm. From the viewpoint of improving abrasion resistance, the average particle size of the filler is preferably 40 nm or more, more preferably 50 nm or more, even more preferably 60 nm or more, and particularly preferably 70 nm or more.
- the average particle size of the filler means the number average primary particle size, and specifically means a value measured as follows. After obtaining a cured product (e.g., the above-mentioned test piece A1) from the photocurable composition of the present disclosure by stereolithography, a cross section of the cured product is cut out, a TEM photograph of the cross section is taken, 100 particles are randomly selected, their circle-equivalent diameters are calculated, and the obtained circle-equivalent diameters are arithmetically averaged (number-averaged).
- a cured product e.g., the above-mentioned test piece A1
- a cross section of the cured product is cut out, a TEM photograph of the cross section is taken, 100 particles are randomly selected, their circle-equivalent diameters are calculated, and the obtained circle-equivalent diameters are arithmetically averaged (number-averaged).
- the content of the filler is preferably 2 parts by mass to 100 parts by mass, more preferably 5 parts by mass to 80 parts by mass, even more preferably 5 parts by mass to 60 parts by mass, and even more preferably 10 parts by mass to 50 parts by mass, relative to 100 parts by mass of the photopolymerizable component.
- the filler may be surface-treated with a surface treatment agent such as a silane coupling agent.
- a surface treatment agent such as a silane coupling agent.
- the surface treatment agent can impart, for example, abrasion resistance to a cured product of the photocurable composition containing the filler.
- the surface treatment agent is not particularly limited, but for example, a silane coupling agent can be used.
- silane coupling agent examples include organic silicon compounds such as methacryloxyalkyltrimethoxysilane (number of carbon atoms between the methacryloxy group and the silicon atom: 3 to 12), methacryloxyalkyltriethoxysilane (number of carbon atoms between the methacryloxy group and the silicon atom: 3 to 12), vinyltrimethoxysilane, vinylethoxysilane, and vinyltriacetoxysilane.
- organic silicon compounds such as methacryloxyalkyltrimethoxysilane (number of carbon atoms between the methacryloxy group and the silicon atom: 3 to 12), methacryloxyalkyltriethoxysilane (number of carbon atoms between the methacryloxy group and the silicon atom: 3 to 12), vinyltrimethoxysilane, vinylethoxysilane, and vinyltriacetoxysilane.
- the photocurable composition of the present disclosure may contain components other than the above-mentioned components, as necessary.
- other components include color materials (pigments, etc.), modifiers, stabilizers, antioxidants, solvents, fluorescent brighteners, etc.
- color materials pigments, etc.
- modifiers modifiers
- stabilizers antioxidants
- solvents fluorescent brighteners
- Each of these other components may be contained in an amount of 0.0001% by mass to 0.1000% by mass relative to the total mass of the photocurable composition.
- the photocurable composition of the present disclosure preferably has a viscosity (hereinafter also simply referred to as "viscosity") measured with an E-type viscometer at 25°C and 50 rpm of 5 mPa ⁇ s to 6000 mPa ⁇ s.
- rpm means revolutions per minute.
- the viscosity is from 5 mPa ⁇ s to 6000 mPa ⁇ s
- the photocurable composition has excellent handleability when a three-dimensional object is produced by stereolithography.
- the viscosity is more preferably 10 mPa ⁇ s to 5000 mPa ⁇ s, even more preferably 20 mPa ⁇ s to 4000 mPa ⁇ s, even more preferably 100 mPa ⁇ s to 3000 mPa ⁇ s, even more preferably 200 mPa ⁇ s to 2000 mPa ⁇ s, and even more preferably 400 mPa ⁇ s to 1500 mPa ⁇ s.
- the photocurable compositions of the present disclosure are preferably photocurable compositions used in the manufacture of dental products.
- dental products include dentures (i.e., artificial teeth), denture bases, dental prostheses, medical instruments for use in the oral cavity, dental models, models for lost-loss casting, and the like.
- dental prostheses include inlays, crowns, bridges, temporary crowns, and temporary bridges.
- medical devices used in the oral cavity include mouthpieces, mouthguards, orthodontic appliances, splints (such as occlusal splints), impression trays, and surgical guides.
- the dental model may include a tooth and jaw model.
- the three-dimensional object of the present disclosure includes a cured product of the photocurable composition of the present disclosure described above.
- the photocurable composition of the present disclosure can be suitably used as a photocurable composition for stereolithography, and more suitably used for producing splints by stereolithography.
- the dental product of the present disclosure includes the three-dimensional object of the present disclosure described above. Specific examples of dental products are described above. As the dental product, a splint including the above-mentioned three-dimensionally shaped object of the present disclosure is preferable.
- Photopolymerizable component 1 urethane diacrylate monomer (Ebecryl 8402, Daicel Allnex Corporation, molecular weight 1000)
- Photopolymerizable component 2 urethane diacrylate monomer (Ebecryl 8807, Daicel Allnex Corporation, molecular weight 1000)
- Photopolymerizable component 3 urethane diacrylate monomer (Ebecryl 230, Daicel Allnex Corporation, molecular weight 5000)
- Photopolymerizable component 4 urethane diacrylate monomer (Ebecryl 270, Daicel Allnex Corporation, molecular weight 2000)
- Photopolymerizable component 5 urethane diacrylate monomer (UA-122P, Shin-Nakamura Chemical Co., Ltd., molecular weight 1100)
- Photopolymerizable component 1 urethane diacrylate monomer (UA-122P, Shin-Nakamura Chemical Co., Ltd., molecular weight 1100)
- Photopolymerizable component 11 ethoxylated bisphenol A diacrylate (ABE-300, Shin-Nakamura Chemical Co., Ltd., molecular weight 469)
- Photopolymerizable component 12 ethoxylated bisphenol A diacrylate (A-BPE-4, Shin-Nakamura Chemical Co., Ltd., molecular weight 513)
- Photopolymerizable component 13 ethoxylated bisphenol A dimethacrylate (SR540, Sartomer Corporation, molecular weight 541)
- Photopolymerizable component 14 urethane diacrylate (UDA, compound produced according to Production Example 1 below, molecular weight 443)
- Photopolymerizable component 15 urethane dimethacrylate (UDMA, Fujifilm Wako Pure Chemical Industries, molecular weight 471)
- Photopolymerizable component 16 Bifunctional urethane acrylate (AH-600, Kyoeisha Chemical Co., Ltd., molecular weight 613)
- Photopolymerizable component 21 benzyl methacrylate (BZ, Kyoeisha Chemical Co., Ltd., molecular weight 176)
- Photopolymerizable component 22 Phenoxyethyl methacrylate (PO, Kyoeisha Chemical Co., Ltd., molecular weight 206)
- Photopolymerizable component 23 Phenoxyethyl acrylate (PO-A, Kyoeisha Chemical Co., Ltd., molecular weight 192)
- Photopolymerizable component 24 m-phenoxybenzyl acrylate (POB-A, Kyoeisha Chemical Co., Ltd., molecular weight 254)
- Photopolymerizable component 25 2-(o-phenylphenoxy)ethyl acrylate (HRD-01, Nisshoku Techno Fine Chemical Co., Ltd., molecular weight 268)
- Photopolymerizable component 26 2-hydroxy-3-phenoxypropyl acrylate (M600-A, Kyoeisha Chemical Co
- Photopolymerizable component 27 tertiary butyl methacrylate (TB, Kyoeisha Chemical Co., Ltd., molecular weight 142)
- Photopolymerizable component 28 cyclohexyl methacrylate (CH, Kyoeisha Chemical Co., Ltd., molecular weight 168)
- Photopolymerizable component 29 Isobornyl methacrylate (IBX, Kyoeisha Chemical Co., Ltd., molecular weight 222)
- Photopolymerizable component 30 Isobornyl acrylate (IBXA, Kyoeisha Chemical Co., Ltd., molecular weight 208)
- Photopolymerizable component 31 Tetrahydrofurfuryl methacrylate (THF (1000), Kyoeisha Chemical Co., Ltd., molecular weight 170)
- Photopolymerization initiator Specific examples of compounds classified as photopolymerization initiators include photopolymerization initiators 1 and 2 shown below.
- Photopolymerization initiator 1 acylphosphine oxide compound (Omnirad TPO: "Omnirad TPO" manufactured by IGM Resins B.V.)
- Photopolymerization initiator 2 acylphosphine oxide compound (Omnirad 819: “Omnirad 819” manufactured by IGM Resins B.V.)
- the reaction temperature was kept at 80 ° C. and the reaction was carried out for 10 hours. At this time, the progress of the reaction was tracked by HPLC analysis to confirm the end point of the reaction.
- UDA bifunctional urethane acrylate
- HEA Hydroxyethyl acrylate
- DBTDL Dibutyltin dilaurate
- MEHQ 4-Methoxyphenol
- TMHDI Mixture of 2,2,4-trimethylhexamethylene diisocyanate and 2,4,4-trimethylhexamethylene diisocyanate
- XDI m-Xylylene diisocyanate
- Photocurable compositions were prepared using the materials shown in Tables 1 to 5.
- the methacryloyl group content of the photocurable compositions prepared in the Comparative Examples and Examples is the ratio of the methacryloyl group content (mol/g) to the total content (mol/g) of the acryloyl group and the methacryloyl group in the composition.
- the results are shown in Tables 1 to 5.
- the obtained test piece is irradiated with ultraviolet light having a wavelength of 365 nm at 10 J/cm 2 to fully cure the photocurable composition, thereby obtaining a cured product of test piece A1.
- the storage modulus of the obtained cured test piece A1 is measured at a frequency of 1 Hz while heating the test piece from 25°C to 100°C at a rate of 3°C/min using a dynamic viscoelasticity measuring device (DVA-225, manufactured by IT Measurement & Control Co., Ltd.), and the storage modulus at 37°C is read.
- DVA-225 dynamic viscoelasticity measuring device
- the obtained test piece is irradiated with ultraviolet light of 365 nm wavelength at 10 J/cm 2 to fully cure the photocurable composition, thereby obtaining a cured product of the test piece.
- the obtained cured test piece was polished on both sides of 50 mm x 40 mm with a rotary polisher (Ecomet 30, manufactured by Buehler) at 150 rpm, 0.15 mm on one side with 400-number abrasive paper, 0.07 mm on one side with 800-number abrasive paper, 0.02 mm on one side with 1000-number abrasive paper, and 0.01 mm on one side with 2000-number abrasive paper, for a total of 0.25 mm, and polished for 15 seconds on each side using Polishing Cloth (MasterTex Polishing Cloth 40-7742, manufactured by Buehler) and 1 g of an abrasive (high-purity alumina powder, particle size 1 ⁇ m, manufactured by Sankei Co., Ltd.
- test piece of 50 mm x 40 mm x 4.5 mm is formed using the photocurable composition to be measured under conditions of a laminate width of 50 ⁇ m and irradiating each layer with visible light of a wavelength of 385 nm at 11 mJ/cm 2 , and then irradiating the formed object with ultraviolet light of a wavelength of 365 nm at an irradiation dose of 10 J/cm 2 to obtain test piece A3.
- the surface condition of test piece A3 is evaluated according to the following criteria. The results are shown in Tables 1 to 5.
- the surface condition of the shaped test pieces A1 and A2 is smooth and not sticky.
- 2 The surface condition of the shaped test pieces A1 and A2 is not sticky, but is not smooth.
- 1 The surface condition of the shaped test pieces A1 and A2 is sticky and not smooth, or no test pieces can be obtained.
- the inability to obtain the test piece refers to, for example, a state in which only a non-cured or gel-like specimen is obtained.
- a photocurable composition containing a photopolymerizable component and a photopolymerization initiator was irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/cm 2 to form a cured layer A1 having a thickness of 50 ⁇ m, and the cured layer A1 was laminated in the thickness direction to form a rectangular plate-shaped object A1 having a length of 40 mm, a width of 10 mm, and a thickness of 1 mm.
- the object A1 was irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/cm 2 to produce a rectangular plate-shaped test piece A1 having a length of 40 mm, a width of 10 mm, and a thickness of 1 mm.
- the storage modulus of the test piece A1 at 37 ° C. was 100 MPa or more and 1500 MPa or less, and high transparency could be ensured while maintaining mechanical strength.
- the object obtained using the photocurable composition of the examples has an excellent balance between mechanical strength and softness, it is presumed that it is less susceptible to wear due to teeth grinding, etc., and that the burden on the wearer when worn in the oral cavity is reduced.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Materials Engineering (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Polymerisation Methods In General (AREA)
Abstract
Description
本開示は、光硬化性組成物、立体造形物、歯科用製品及びスプリントに関する。 This disclosure relates to photocurable compositions, three-dimensional objects, dental products, and splints.
近年、歯科用補綴物、口腔内で使用される器具などの歯科用製品に関する検討がなされている。例えば、これら歯科用製品の造形の効率の観点で、3Dプリンターを用いた光造形により歯科用製品等の立体造形物を製造する方法が知られている(例えば、特許第4160311号公報)。 In recent years, dental products such as dental prostheses and instruments used in the oral cavity have been studied. For example, from the perspective of the efficiency of molding these dental products, a method of manufacturing three-dimensional objects such as dental products by stereolithography using a 3D printer is known (for example, Patent No. 4160311).
歯科用製品(例えば、歯科用スプリント)は、主に口腔内に装着されて用いられ、歯軋り等により繰り返し噛み込まれることで、摩耗する。
他方、口腔内に装着する際などに歯に強い負荷がかかり、装着者が痛みを感じてしまう場合があり、装着者の負担が大きい場合がある。
Dental products (for example, dental splints) are primarily used by being worn in the oral cavity, and are subject to wear due to repeated biting caused by teeth grinding or the like.
On the other hand, when the dental prosthesis is placed in the oral cavity, a strong load is applied to the teeth, which may cause pain to the wearer, and may place a large burden on the wearer.
本開示の一実施形態が解決しようとする課題は、歯軋り等に対して摩耗しにくく、かつ、口腔内装着される際の装着者の負担が軽減される立体造形物を製造できる光硬化性組成物、並びに、そのような立体造形物、歯科用製品及びスプリントを提供することである。 The problem that one embodiment of the present disclosure aims to solve is to provide a photocurable composition that can be used to produce a three-dimensional object that is resistant to wear due to teeth grinding and the like and reduces the burden on the wearer when worn in the oral cavity, as well as to provide such a three-dimensional object, a dental product, and a splint.
上記課題を解決する手段には、以下の態様が含まれる。
<1> 光重合性成分と、光重合開始剤とを含有する光硬化性組成物であって、前記光硬化性組成物に対し波長385nmの可視光を照射量11mJ/cm2にて照射して厚さ50μmの硬化層A1を形成し、前記硬化層A1を厚さ方向に積層させることにより、長さ40mm、幅10mm、厚さ1mmの矩形板形状の造形物A1を形成し、前記造形物A1に対し、波長365nmの紫外線を照射量10J/cm2照射することにより、長さ40mm、幅10mm、厚さ1mmの矩形板形状の試験片A1を作製した場合に、前記試験片A1の37℃での貯蔵弾性率が100MPa以上1500MPa以下である光硬化性組成物。
<2> 前記光硬化性組成物に対し波長385nmの可視光を照射量11mJ/cm2にて照射して厚さ50μmの硬化層A2を形成し、前記硬化層A2を厚さ方向に積層させることにより、長さ50mm、幅40mm、厚さ4.5mmの矩形板形状の造形物A2を形成し、前記造形物A2に対し、波長365nmの紫外線を照射量10J/cm2照射した後に、50mm×40mmの面を両面研磨することにより、長さ50mm、幅40mm、厚さ4.0mmの矩形板形状の試験片A2を作製した場合に、前記試験片A2のΔE*
abが10.0以下である<1>に記載の光硬化性組成物。
<3> 前記光重合性成分は、2つの(メタ)アクリロイルオキシ基を含み、分子量が1000以上である(メタ)アクリルモノマー(A)と、2つの(メタ)アクリロイルオキシ基を含み、分子量が170以上1000未満である(メタ)アクリルモノマー(B)と、1つの(メタ)アクリロイルオキシ基を含み、芳香環構造を含む(メタ)アクリルモノマー(C)と、を含む<1>又は<2>に記載の光硬化性組成物。
<4> 前記(メタ)アクリルモノマー(A)がウレタン結合を更に含む<3>に記載の光硬化性組成物。
<5> 前記(メタ)アクリルモノマー(C)の分子量が140~500である<3>又は<4>に記載の光硬化性組成物。
<6> 前記(メタ)アクリルモノマー(A)の含有量が、(メタ)アクリルモノマー成分の全量に対し、5質量%~60質量%である<3>~<5>のいずれか1つに記載の光硬化性組成物。
<7> 前記(メタ)アクリルモノマー(B)の含有量が、(メタ)アクリルモノマー成分の全量に対し、15質量%~80質量%である<3>~<6>のいずれか1つに記載の光硬化性組成物。
<8> 前記(メタ)アクリルモノマー(C)の含有量が、(メタ)アクリルモノマー成分の全量に対し、5質量%~70質量%である<3>~<7>のいずれか1つに記載の光硬化性組成物。
<9> 前記光重合性成分において、アクリロイル基とメタクリロイル基との合計含有量(mol/g)に対するメタクリロイル基の含有量(mol/g)が、0%~90%である<3>~<8>のいずれか1つに記載の光硬化性組成物。
<10> 前記光重合開始剤が、アシルフォスフィンオキサイド化合物を含む<1>~<9>のいずれ1つに記載の光硬化性組成物。
<11> E型粘度計により25℃及び50rpmの条件で測定される粘度が、5mPa・s~6000mPa・sである<1>~<10>のいずれか1つに記載の光硬化性組成物。
<12> 光造形用の光硬化性組成物である<1>~<11>のいずれか1つに記載の光硬化性組成物。
<13> 光造形によるスプリントの製造に用いられる<1>~<12>のいずれか1つに記載の光硬化性組成物。
<14> <1>~<13>のいずれか1つに記載の光硬化性組成物の硬化物を含む立体造形物。
<15> <14>に記載の立体造形物を含む歯科用製品。
<16> <14>に記載の立体造形物を含むスプリント。
Means for solving the above problems include the following aspects.
<1> A photocurable composition comprising a photopolymerizable component and a photopolymerization initiator, the photocurable composition being irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/ cm2 to form a cured layer A1 of 50 μm in thickness, the cured layer A1 being laminated in the thickness direction to form a rectangular plate-shaped object A1 of length 40 mm, width 10 mm and thickness 1 mm, and the shaped object A1 being irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 to produce a rectangular plate-shaped test piece A1 of length 40 mm, width 10 mm and thickness 1 mm, the photocurable composition having a storage modulus at 37° C. of 100 MPa or more and 1500 MPa or less.
<2> The photocurable composition according to <1>, wherein the photocurable composition is irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/ cm2 to form a cured layer A2 having a thickness of 50 μm, the cured layer A2 is laminated in a thickness direction to form a rectangular plate-shaped object A2 having a length of 50 mm, a width of 40 mm and a thickness of 4.5 mm, the shaped object A2 is irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 , and then a 50 mm × 40 mm surface is double-polished to prepare a rectangular plate-shaped test piece A2 having a length of 50 mm, a width of 40 mm and a thickness of 4.0 mm. In this case, ΔE * ab of the test piece A2 is 10.0 or less.
<3> The photocurable composition according to <1> or <2>, wherein the photopolymerizable component includes: a (meth)acrylic monomer (A) containing two (meth)acryloyloxy groups and having a molecular weight of 1,000 or more; a (meth)acrylic monomer (B) containing two (meth)acryloyloxy groups and having a molecular weight of 170 or more and less than 1,000; and a (meth)acrylic monomer (C) containing one (meth)acryloyloxy group and having an aromatic ring structure.
<4> The photocurable composition according to <3>, wherein the (meth)acrylic monomer (A) further contains a urethane bond.
<5> The photocurable composition according to <3> or <4>, wherein the (meth)acrylic monomer (C) has a molecular weight of 140 to 500.
<6> The photocurable composition according to any one of <3> to <5>, wherein the content of the (meth)acrylic monomer (A) is 5% by mass to 60% by mass based on the total amount of the (meth)acrylic monomer components.
<7> The photocurable composition according to any one of <3> to <6>, wherein the content of the (meth)acrylic monomer (B) is 15% by mass to 80% by mass based on the total amount of the (meth)acrylic monomer components.
<8> The photocurable composition according to any one of <3> to <7>, wherein the content of the (meth)acrylic monomer (C) is 5% by mass to 70% by mass based on the total amount of the (meth)acrylic monomer components.
<9> The photocurable composition according to any one of <3> to <8>, in which the content (mol/g) of methacryloyl groups relative to the total content (mol/g) of acryloyl groups and methacryloyl groups in the photopolymerizable component is 0% to 90%.
<10> The photocurable composition according to any one of <1> to <9>, wherein the photopolymerization initiator contains an acylphosphine oxide compound.
<11> The photocurable composition according to any one of <1> to <10>, which has a viscosity of 5 mPa·s to 6,000 mPa·s as measured with an E-type viscometer at 25° C. and 50 rpm.
<12> The photocurable composition according to any one of <1> to <11>, which is a photocurable composition for stereolithography.
<13> The photocurable composition according to any one of <1> to <12>, which is used for producing a splint by stereolithography.
<14> A three-dimensional object comprising a cured product of the photocurable composition according to any one of <1> to <13>.
<15> A dental product comprising the three-dimensional object according to <14>.
<16> A splint including the three-dimensional object according to <14>.
本開示の一実施形態によれば、歯軋り等に対して摩耗しにくく、かつ、口腔内装着される際の装着者の負担が軽減される立体造形物を製造できる光硬化性組成物、並びに、そのような立体造形物、歯科用製品及びスプリントを提供できる。 According to one embodiment of the present disclosure, it is possible to provide a photocurable composition capable of producing a three-dimensional object that is resistant to wear due to teeth grinding and the like and reduces the burden on the wearer when worn in the oral cavity, as well as such a three-dimensional object, a dental product, and a splint.
本開示において、「~」を用いて表される数値範囲は、「~」の前後に記載される数値を下限値及び上限値として含む範囲を意味する。
本開示において、「工程」との用語は、独立した工程だけではなく、他の工程と明確に区別できない場合であってもその工程の所期の目的が達成されれば、本用語に含まれる。
本開示において、組成物に含まれる各成分の量は、組成物中に各成分に該当する物質が複数存在する場合は、特に断らない限り、組成物中に存在する当該複数の物質の合計量を意味する。
本開示中に段階的に記載されている数値範囲において、一つの数値範囲で記載された上限値又は下限値は、他の段階的な記載の数値範囲の上限値又は下限値に置き換えてもよい。また、本開示中に記載されている数値範囲において、その数値範囲の上限値又は下限値は、実施例に示されている値に置き換えてもよい。
本開示において、「光」は、紫外線、可視光線等の活性エネルギー線を包含する概念である。
In the present disclosure, a numerical range expressed using "to" means a range that includes the numerical values before and after "to" as the lower and upper limits.
In the present disclosure, the term "process" refers not only to an independent process, but also to a process that cannot be clearly distinguished from other processes, as long as the intended purpose of the process is achieved.
In the present disclosure, when a plurality of substances corresponding to each component are present in the composition, the amount of each component contained in the composition means the total amount of the plurality of substances present in the composition, unless otherwise specified.
In the numerical ranges described in the present disclosure in stages, the upper or lower limit value described in one numerical range may be replaced with the upper or lower limit value of another numerical range described in stages. In addition, in the numerical ranges described in the present disclosure, the upper or lower limit value of the numerical range may be replaced with a value shown in the examples.
In the present disclosure, the term "light" is a concept that encompasses active energy rays such as ultraviolet light and visible light.
本開示において、「(メタ)アクリレート」はアクリレート又はメタクリレートを意味し、「(メタ)アクリロイル」はアクリロイル又はメタクリロイルを意味し、「(メタ)アクリル」はアクリル又はメタクリルを意味する。 In this disclosure, "(meth)acrylate" means acrylate or methacrylate, "(meth)acryloyl" means acryloyl or methacryloyl, and "(meth)acrylic" means acrylic or methacrylic.
≪光硬化性組成物≫
本開示の光硬化性組成物は、光重合性成分と、光重合開始剤とを含有する光硬化性組成物であって、光硬化性組成物に対し波長385nmの可視光を照射量11mJ/cm2にて照射して厚さ50μmの硬化層A1を形成し、硬化層A1を厚さ方向に積層させることにより、長さ40mm、幅10mm、厚さ1mmの矩形板形状の造形物A1を形成し、造形物A1に対し、波長365nmの紫外線を照射量10J/cm2照射することにより、長さ40mm、幅10mm、厚さ1mmの矩形板形状の試験片A1を作製した場合に、試験片A1の37℃での貯蔵弾性率が100MPa以上1500MPa以下である。
<Photocurable composition>
The photocurable composition of the present disclosure is a photocurable composition containing a photopolymerizable component and a photopolymerization initiator, and the photocurable composition is irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/cm2 to form a cured layer A1 of a thickness of 50 μm, and the cured layer A1 is laminated in the thickness direction to form a rectangular plate-shaped object A1 of length 40 mm, width 10 mm, and thickness 1 mm. The object A1 is irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 to produce a rectangular plate-shaped test piece A1 of length 40 mm, width 10 mm, and thickness 1 mm. The storage modulus of the test piece A1 at 37° C. is 100 MPa or more and 1500 MPa or less.
本開示の光硬化性組成物は、上記構成を含むことで、歯軋り等に対して摩耗しにくく、かつ、口腔内装着される際の装着者の負担が軽減される立体造形物を製造できる。 The photocurable composition disclosed herein, by containing the above-mentioned components, can produce a three-dimensional object that is resistant to wear due to teeth grinding and the like, and reduces the burden on the wearer when worn in the oral cavity.
光造形としては、例えば、液槽方式の光造形(即ち、液槽を用いる光造形)が知られている。
液槽方式の光造形では、液槽内に収容された光硬化性組成物(即ち、液体状態の未硬化の光硬化性組成物。以下同じ。)の一部を光照射によって硬化させて硬化層を形成し、この操作を繰り返すことで硬化層を積層させ、これにより立体造形物を得る。液槽方式の光造形は、液槽を用いる点で、インクジェット方式の光造形とは異なる。
液槽方式の光造形は、DLP(Digital Light Processing)方式の光造形及びSLA(Stereolithography)方式の光造形に大別される。DLP方式では、液槽内の光硬化性組成物に対し、面状の光を照射する。SLA方式では、液槽内の光硬化性組成物に対し、レーザー光を走査する。
As an example of stereolithography, liquid tank type stereolithography (that is, stereolithography using a liquid tank) is known.
In liquid tank type stereolithography, a portion of the photocurable composition (i.e., an uncured photocurable composition in a liquid state; the same applies below) contained in a liquid tank is cured by irradiation with light to form a cured layer, and this operation is repeated to stack the cured layers, thereby obtaining a three-dimensional object. Liquid tank type stereolithography differs from inkjet type stereolithography in that a liquid tank is used.
The liquid vat type stereolithography is broadly divided into DLP (Digital Light Processing) type stereolithography and SLA (Stereolithography) type stereolithography. In the DLP type, a light beam is irradiated onto a photocurable composition in a liquid vat in a planar manner. In the SLA type, a laser beam is scanned onto a photocurable composition in a liquid vat.
DLP方式の光造形の一例では、例えば、
鉛直方向に移動可能なビルドテーブルと、
ビルドテーブルの下方(重力方向側。以下同じ。)に配置され、光透過性部を含み、光硬化性組成物が収容されるトレー(即ち、液槽)と、
トレーの下方に配置され、トレー内の光硬化性組成物に対し、トレーの光透過性部を介して面状の光を照射するための光源(例えば、LED光源)と、
を備える3Dプリンター(例えば、Kulzer社製の「Cara Print4.0」、Asiga社製の「Max UV」、等)が用いられる。
この一例では、まず、ビルドテーブルとトレーとの間に一層分のギャップを設け、このギャップを、光硬化性組成物で満たす。次に、ギャップに満たされた光硬化性組成物に対し、下方から、トレーの光透過性部を介して面状の光を照射し、光が照射された領域を硬化させることにより、一層目の硬化層を形成する。次に、ビルドテーブルとトレーとのギャップを次の一層分広げ、生じた空間を光硬化性組成物で満たす。次に、空間に満たされた光硬化性組成物に対し、一層目の硬化と同様にして光を照射し、二層目の硬化層を形成する。以上の操作を繰り返すことにより、硬化層を積層させ、立体造形物を製造する。この一例において、製造された立体造形物に対し、さらに光を照射することにより、立体造形物をさらに硬化させてもよい。
In an example of DLP type stereolithography, for example,
a build table that is vertically movable;
a tray (i.e., a liquid tank) that is disposed below the build table (on the side in the direction of gravity; the same applies below), includes a light-transmitting portion, and contains a photocurable composition;
a light source (e.g., an LED light source) disposed below the tray for irradiating the photocurable composition in the tray with planar light through a light-transmitting portion of the tray;
In this case, a 3D printer equipped with the above function (e.g., "Cara Print 4.0" manufactured by Kulzer, "Max UV" manufactured by Asiga, etc.) is used.
In this example, first, a gap of one layer is provided between the build table and the tray, and the gap is filled with the photocurable composition. Next, the photocurable composition filled in the gap is irradiated with planar light from below through the light-transmitting portion of the tray, and the area irradiated with light is cured to form a first cured layer. Next, the gap between the build table and the tray is widened by the next layer, and the resulting space is filled with the photocurable composition. Next, the photocurable composition filled in the space is irradiated with light in the same manner as the curing of the first layer, and a second cured layer is formed. By repeating the above operations, the cured layers are stacked to produce a three-dimensional object. In this example, the three-dimensional object produced may be further cured by further irradiating the three-dimensional object with light.
<37℃での貯蔵弾性率>
本開示の光硬化性組成物は、光硬化性組成物に対し波長385nmの可視光を照射量11mJ/cm2にて照射して厚さ50μmの硬化層A1を形成し、硬化層A1を厚さ方向に積層させることにより、長さ40mm、幅10mm、厚さ1mmの矩形板形状の造形物A1を形成し、造形物A1に対し、波長365nmの紫外線を照射量10J/cm2照射することにより、長さ40mm、幅10mm、厚さ1mmの矩形板形状の試験片A1を作製した場合に、試験片A1の37℃での貯蔵弾性率が100MPa以上1500MPa以下である。
<Storage modulus at 37° C.>
The photocurable composition of the present disclosure is irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/ cm2 to form a cured layer A1 of a thickness of 50 μm, and the cured layer A1 is laminated in the thickness direction to form a rectangular plate-shaped object A1 of length 40 mm, width 10 mm and thickness 1 mm. The shaped object A1 is irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 to produce a rectangular plate-shaped test piece A1 of length 40 mm, width 10 mm and thickness 1 mm. The storage modulus of the test piece A1 at 37° C. is 100 MPa or more and 1500 MPa or less.
37℃での貯蔵弾性率は、歯軋り等に対して摩耗しにくい観点から、好ましくは150MPa以上であり、より好ましくは200MPa以上であり、さらに好ましくは300MPa以上であり、特に好ましくは400MPa以上である。 The storage modulus at 37°C is preferably 150 MPa or more, more preferably 200 MPa or more, even more preferably 300 MPa or more, and particularly preferably 400 MPa or more, from the viewpoint of resistance to wear due to teeth grinding, etc.
37℃での貯蔵弾性率は、口腔内装着される際の装着者の負担が軽減される観点から、好ましくは1400MPa以下であり、より好ましくは1200MPa以下であり、さらに好ましくは1000MPa以下であり、特に好ましくは800MPa以下である。 The storage modulus at 37°C is preferably 1400 MPa or less, more preferably 1200 MPa or less, even more preferably 1000 MPa or less, and particularly preferably 800 MPa or less, from the viewpoint of reducing the burden on the wearer when the device is worn in the oral cavity.
(試験片A1)
試験片A1は、長さ40mm、幅10mm、厚さ1mmの矩形板形状の試験片である。
試験片A1は、本開示の光硬化性組成物に対し波長385nmの可視光を照射量11mJ/cm2にて照射して厚さ50μmの硬化層A1を形成し、硬化層A1を厚さ方向に積層させることにより、長さ40mm、幅10mm、厚さ1mmの矩形板形状の造形物A1を形成し、造形物A1に対し、波長365nmの紫外線を照射量10J/cm2照射する条件の光造形によって作製される。
試験片A1は、例えば、前述したDLP方式の光造形の一例に従って作製できる。
DLP方式の3Dプリンターである、Kulzer社製「Cara Print4.0」を用いて、試験片A1を作製してもよい。
(Test Piece A1)
The test piece A1 is a rectangular plate-shaped test piece having a length of 40 mm, a width of 10 mm, and a thickness of 1 mm.
Test piece A1 was produced by photopolymerization under the following conditions: the photocurable composition of the present disclosure was irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/ cm2 to form a cured layer A1 with a thickness of 50 μm, the cured layer A1 was then stacked in the thickness direction to form a rectangular plate-shaped object A1 with a length of 40 mm, a width of 10 mm and a thickness of 1 mm, and the object A1 was then irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 .
The test piece A1 can be produced, for example, according to an example of the DLP type stereolithography described above.
The test piece A1 may be produced using a DLP type 3D printer, "Cara Print 4.0" manufactured by Kulzer.
(貯蔵弾性率の測定)
本開示における37℃での貯蔵弾性率は、詳細には、動的粘弾性測定により、昇温範囲25℃~300℃及び昇温速度3℃/分にて昇温しながら測定周波数1Hzの条件にて貯蔵弾性率を測定した場合の、37℃における貯蔵弾性率である。
動的粘弾性測定の装置として、株式会社日立ハイテク製の動的粘弾性測定装置「DMA7100」を用いてもよい。
(Measurement of storage modulus)
In the present disclosure, the storage modulus at 37° C. is, in particular, the storage modulus at 37° C. measured by dynamic viscoelasticity measurement under conditions of a temperature rise range of 25° C. to 300° C. at a temperature rise rate of 3° C./min at a measurement frequency of 1 Hz.
As a dynamic viscoelasticity measuring device, a dynamic viscoelasticity measuring device "DMA7100" manufactured by Hitachi High-Tech Corporation may be used.
<ΔE*
ab>
本開示の光硬化性組成物は、光硬化性組成物に対し波長385nmの可視光を照射量11mJ/cm2にて照射して厚さ50μmの硬化層A2を形成し、硬化層A2を厚さ方向に積層させることにより、長さ50mm、幅40mm、厚さ4.5mmの矩形板形状の造形物A2を形成し、造形物A2に対し、波長365nmの紫外線を照射量10J/cm2照射した後に、50mm×40mmの面を両面研磨することにより、長さ50mm、幅40mm、厚さ4.0mmの矩形板形状の試験片A2を作製した場合に、試験片A2のΔE*
abが10.0以下であることが好ましい。
<ΔE * ab >
In the photocurable composition of the present disclosure, the photocurable composition is irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/ cm2 to form a cured layer A2 of a thickness of 50 μm, and the cured layer A2 is laminated in the thickness direction to form a rectangular plate-shaped object A2 of a length of 50 mm, a width of 40 mm, and a thickness of 4.5 mm. The object A2 is then irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 , and the 50 mm x 40 mm surfaces are then double-polished to produce a rectangular plate-shaped test piece A2 of a length of 50 mm, a width of 40 mm, and a thickness of 4.0 mm. In this case, it is preferable that the ΔE * ab of test piece A2 is 10.0 or less.
ΔE* abは、得られる硬化物の透明性の観点から、より好ましくは6.0以下であり、さらに好ましくは5.5以下であり、特に好ましくは5.0以下であり、最も好ましくは4.5MPa以下である。 From the viewpoint of transparency of the resulting cured product, ΔE * ab is more preferably 6.0 or less, further preferably 5.5 or less, particularly preferably 5.0 or less, and most preferably 4.5 MPa or less.
ΔE*
abは、下限値に特に制限はなく、0超であってもよく、0.1以上であってもよく、1.0以上であってもよい。
硬化物の透明性の要求度が抑制される場合は、ΔE*
abは、下限値が6.0超であってもよい。
There is no particular restriction on the lower limit of ΔE * ab , and it may be more than 0, 0.1 or more, or 1.0 or more.
When the requirement for transparency of the cured product is low, the lower limit of ΔE * ab may be more than 6.0.
(試験片A2)
試験片A2は、長さ50mm、幅40mm、厚さ4.0mmの矩形板形状の試験片である。
試験片A2は、本開示の光硬化性組成物に対し波長385nmの可視光を照射量11mJ/cm2にて照射して厚さ50μmの硬化層A2を形成し、硬化層A2を厚さ方向に積層させることにより、長さ50mm、幅40mm、厚さ4.5mmの矩形板形状の造形物A2を形成し、造形物A2に対し、波長365nmの紫外線を照射量10J/cm2照射した後に、50mm×40mmの面を両面研磨することによって作製される。
試験片A2は、例えば、前述したDLP方式の光造形の一例に従って作製できる。
DLP方式の3Dプリンターである、Kulzer社製「Cara Print4.0」を用いて、試験片A2を作製してもよい。
(Test Piece A2)
The test piece A2 is a rectangular plate-shaped test piece having a length of 50 mm, a width of 40 mm, and a thickness of 4.0 mm.
Test piece A2 was produced by irradiating the photocurable composition of the present disclosure with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/ cm2 to form a cured layer A2 with a thickness of 50 μm, stacking the cured layer A2 in the thickness direction to form a rectangular plate-shaped object A2 with a length of 50 mm, a width of 40 mm, and a thickness of 4.5 mm, irradiating object A2 with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 , and then polishing both sides of the 50 mm x 40 mm surfaces.
The test piece A2 can be produced, for example, according to an example of the DLP type stereolithography described above.
The test piece A2 may be produced using a DLP type 3D printer, "Cara Print 4.0" manufactured by Kulzer.
(ΔE*
abの測定)
本開示におけるΔE*
abは、詳細には、色差計にて、50mm×40mmの面のL*a*b*を透過モードによって、付属のSTANDARD WHITE PLATE(SCI X:94.25、Y:99.44、Z:106.37)をリファレンスとして測定する。50mm×40mm×4.0mmの透明PMMA板(旭製作所、L*=96.98、a*=-0.24、b*=0.05;「SCI X:94.25、Y:99.44、Z:106.37」をリファレンスとする色の数値)のL*a*b*を基準色として、ΔE*
ab=(ΔL2+Δa2+Δb2)1/2の計算式にて、ΔE*
abを算出する。
色差計としては、日本電色工業株式会社製のSD3000を用いてもよい。
(Measurement of ΔE * ab )
In this disclosure, ΔE * ab is measured by a color difference meter in transmission mode for the L * a * b * of a 50mm x 40mm surface, using the attached STANDARD WHITE PLATE (SCI X: 94.25, Y: 99.44, Z: 106.37) as a reference. ΔE*ab is calculated by the formula ΔE * ab = (ΔL2 + Δa2 + Δb2) 1/2, using the L * a * b * of a 50mm x 40mm x 4.0mm transparent PMMA plate (Asahi Manufacturing, L* = 96.98, a * = -0.24, b * = 0.05; color values based on "SCI X: 94.25, Y : 99.44, Z: 106.37" as a reference color ).
As the color difference meter, SD3000 manufactured by Nippon Denshoku Industries Co., Ltd. may be used.
<光重合性成分>
本開示の光硬化性組成物は、光重合性成分を少なくとも1種含有する。
光重合性成分としては、エチレン性二重結合を含む化合物が挙げられる。
エチレン性二重結合を含む化合物としては、(メタ)アクリルモノマー、スチレン、スチレン誘導体、(メタ)アクリロニトリル、等が挙げられる。
<Photopolymerizable component>
The photocurable compositions of the present disclosure contain at least one photopolymerizable component.
The photopolymerizable component includes a compound containing an ethylenic double bond.
Examples of the compound containing an ethylenic double bond include (meth)acrylic monomers, styrene, styrene derivatives, and (meth)acrylonitrile.
光重合性成分としては、国際公開第2019/189652号の段落0030~段落0059に記載の光重合性成分を用いてもよい。 As the photopolymerizable component, the photopolymerizable components described in paragraphs 0030 to 0059 of WO 2019/189652 may be used.
本開示の光硬化性組成物の全量に対する光重合性成分の含有量は、60質量%以上であることが好ましく、80質量%以上であることがより好ましく、90質量%以上であることがさらに好ましい。 The content of the photopolymerizable component in the total amount of the photocurable composition of the present disclosure is preferably 60% by mass or more, more preferably 80% by mass or more, and even more preferably 90% by mass or more.
光重合性成分は、(メタ)アクリルモノマーを少なくとも1種含むことが好ましい。
ここで、(メタ)アクリルモノマーとは、1つ以上の(メタ)アクリロイル基を有するモノマーを意味する。(メタ)アクリルモノマーとしては、1つ以上の(メタ)アクリロイルオキシ基を有するモノマーが好ましい。
The photopolymerizable component preferably contains at least one (meth)acrylic monomer.
Here, the (meth)acrylic monomer means a monomer having one or more (meth)acryloyl groups. As the (meth)acrylic monomer, a monomer having one or more (meth)acryloyloxy groups is preferable.
本開示では、光硬化性組成物に含有される全ての(メタ)アクリルモノマーを、「(メタ)アクリルモノマー成分」と称することがあり、本開示の光硬化性組成物に含有される全ての(メタ)アクリルモノマーの合計含有量を、「(メタ)アクリルモノマー成分の全量」と称することがある。 In this disclosure, all (meth)acrylic monomers contained in the photocurable composition may be referred to as "(meth)acrylic monomer components," and the total content of all (meth)acrylic monomers contained in the photocurable composition of this disclosure may be referred to as "total amount of (meth)acrylic monomer components."
歯軋り等に対して摩耗しにくく、かつ、口腔内装着される際の装着者の負担が軽減される観点から、本開示の光硬化性組成物中の光重合性成分の全量に対する(メタ)アクリルモノマー成分の全量は、80質量%以上であることが好ましく、90質量%以上であることがより好ましく、95質量%以上であることがさらに好ましい。 From the viewpoint of being resistant to wear due to teeth grinding, etc., and reducing the burden on the wearer when worn in the oral cavity, the total amount of (meth)acrylic monomer components relative to the total amount of photopolymerizable components in the photocurable composition of the present disclosure is preferably 80% by mass or more, more preferably 90% by mass or more, and even more preferably 95% by mass or more.
歯軋り等に対して摩耗しにくく、かつ、口腔内装着される際の装着者の負担が軽減される観点から、本開示の光硬化性組成物の全量に対する(メタ)アクリルモノマー成分の全量は、60質量%以上であることが好ましく、80質量%以上であることがより好ましく、90質量%以上であることが更に好ましい。 From the viewpoint of being resistant to wear due to teeth grinding and the like, and reducing the burden on the wearer when worn in the oral cavity, the total amount of (meth)acrylic monomer components relative to the total amount of the photocurable composition of the present disclosure is preferably 60% by mass or more, more preferably 80% by mass or more, and even more preferably 90% by mass or more.
(メタ)アクリルモノマー成分を構成する(メタ)アクリルモノマーとしては、1つ以上の(メタ)アクリロイル基を有するモノマーであればよく、その他には特に制限はない。
(メタ)アクリルモノマーは、
1つの(メタ)アクリロイル基を有するモノ(メタ)アクリルモノマー(以下、「単官能(メタ)アクリルモノマー」ともいう)であってもよいし、
2つの(メタ)アクリロイル基を有するジ(メタ)アクリルモノマー(以下、「二官能(メタ)アクリルモノマー」ともいう)であってもよいし、
3つ以上の(メタ)アクリロイル基を有するポリ(メタ)アクリルモノマー(以下、「多官能(メタ)アクリルモノマー」ともいう)であってもよい。
The (meth)acrylic monomer constituting the (meth)acrylic monomer component is not particularly limited as long as it is a monomer having one or more (meth)acryloyl groups.
The (meth)acrylic monomer is
It may be a mono(meth)acrylic monomer having one (meth)acryloyl group (hereinafter also referred to as a "monofunctional (meth)acrylic monomer");
It may be a di(meth)acrylic monomer having two (meth)acryloyl groups (hereinafter also referred to as a "bifunctional (meth)acrylic monomer");
It may be a poly(meth)acrylic monomer having three or more (meth)acryloyl groups (hereinafter also referred to as a "polyfunctional (meth)acrylic monomer").
モノ(メタ)アクリルモノマーとしては、1つの(メタ)アクリロイルオキシ基を有するモノ(メタ)アクリルモノマーが好ましい。
ジ(メタ)アクリルモノマーとしては、2つの(メタ)アクリロイルオキシ基を有するジ(メタ)アクリルモノマーが好ましい。
トリ(メタ)アクリルモノマーとしては、3つ以上の(メタ)アクリロイルオキシ基を有するポリ(メタ)アクリルモノマーが好ましい。
The mono(meth)acrylic monomer is preferably a mono(meth)acrylic monomer having one (meth)acryloyloxy group.
The di(meth)acrylic monomer is preferably a di(meth)acrylic monomer having two (meth)acryloyloxy groups.
The tri(meth)acrylic monomer is preferably a poly(meth)acrylic monomer having three or more (meth)acryloyloxy groups.
光重合性成分は、
2つの(メタ)アクリロイルオキシ基を含み、分子量が1000以上である(メタ)アクリルモノマー(A)、
2つの(メタ)アクリロイルオキシ基を含み、分子量が170以上1000未満である(メタ)アクリルモノマー(B)、及び、
1つの(メタ)アクリロイルオキシ基を含み、芳香環構造を含む(メタ)アクリルモノマー(C)
のうちの少なくとも1つを含むことが好ましい。
The photopolymerizable component is
A (meth)acrylic monomer (A) containing two (meth)acryloyloxy groups and having a molecular weight of 1,000 or more;
(B) a (meth)acrylic monomer containing two (meth)acryloyloxy groups and having a molecular weight of 170 or more and less than 1,000; and
(C) a (meth)acrylic monomer containing one (meth)acryloyloxy group and containing an aromatic ring structure
It is preferable to include at least one of the following:
光重合性成分は、
2つの(メタ)アクリロイルオキシ基を含み、分子量が1000以上である(メタ)アクリルモノマー(A)と、
2つの(メタ)アクリロイルオキシ基を含み、分子量が170以上1000未満である(メタ)アクリルモノマー(B)と、
1つの(メタ)アクリロイルオキシ基を含み、芳香環構造を含む(メタ)アクリルモノマー(C)と、
を含むことがより好ましい。
かかる条件を満足する場合には、37℃での貯蔵弾性率を上述の範囲内に調整しやすい。
The photopolymerizable component is
A (meth)acrylic monomer (A) containing two (meth)acryloyloxy groups and having a molecular weight of 1000 or more;
a (meth)acrylic monomer (B) containing two (meth)acryloyloxy groups and having a molecular weight of 170 or more and less than 1,000;
A (meth)acrylic monomer (C) containing one (meth)acryloyloxy group and containing an aromatic ring structure;
It is more preferred that the composition comprises:
When these conditions are satisfied, the storage modulus at 37° C. can be easily adjusted to fall within the above range.
((メタ)アクリルモノマー(A))
(メタ)アクリルモノマー(A)は、2つの(メタ)アクリロイルオキシ基を含み、分子量が1000以上である。
光重合性成分が(メタ)アクリルモノマー(A)を含むことで、得られる硬化物における柔らかさを向上させることができ(すなわち、37℃での貯蔵弾性率の数値を下げるように調整でき)、反応性にも優れる。
((Meth)acrylic monomer (A))
The (meth)acrylic monomer (A) contains two (meth)acryloyloxy groups and has a molecular weight of 1,000 or more.
When the photopolymerizable component contains the (meth)acrylic monomer (A), the softness of the obtained cured product can be improved (i.e., the storage modulus at 37°C can be adjusted to be lowered), and the reactivity is also excellent.
(メタ)アクリルモノマー(A)の分子量は、1000以上であり、好ましくは1300以上であり、より好ましくは1700以上であり、さらに好ましくは2100以上である。
(メタ)アクリルモノマー(A)の分子量の上限は、特に制限はない。
(メタ)アクリルモノマー(A)の分子量は、20000以下であってもよく、10000以下であることが好ましく、より好ましくは8000以下であり、さらに好ましくは6000以下である。
(メタ)アクリルモノマー(A)の分子量は、好ましくは1000以上15000以下、より好ましくは1000以上10000以下である。
The molecular weight of the (meth)acrylic monomer (A) is 1,000 or more, preferably 1,300 or more, more preferably 1,700 or more, and even more preferably 2,100 or more.
There is no particular upper limit to the molecular weight of the (meth)acrylic monomer (A).
The molecular weight of the (meth)acrylic monomer (A) may be 20,000 or less, preferably 10,000 or less, more preferably 8,000 or less, and even more preferably 6,000 or less.
The molecular weight of the (meth)acrylic monomer (A) is preferably 1,000 or more and 15,000 or less, and more preferably 1,000 or more and 10,000 or less.
(メタ)アクリルモノマー(A)は、ウレタン結合を含むことが好ましい。
つまり、(メタ)アクリルモノマー(A)は、ウレタンジアクリレートモノマーであることが好ましい。
これによって、得られる硬化物における靭性に優れる。
The (meth)acrylic monomer (A) preferably contains a urethane bond.
That is, the (meth)acrylic monomer (A) is preferably a urethane diacrylate monomer.
This provides the resulting cured product with excellent toughness.
(メタ)アクリルモノマー(A)としては、以下の一般式(A1)で表される化合物が好ましい。 The (meth)acrylic monomer (A) is preferably a compound represented by the following general formula (A1):
式(A1)中、R1は、それぞれ独立に2価の有機基であり、R2はそれぞれ独立に置換基を有していてもよい2価の炭化水素基であり、R3は、それぞれ独立に水素原子又はメチル基であり、Xは2価の有機基であり、nは0~10の整数である。複数存在するR1、R2、R3は、それぞれ同一であっても異なっていてもよく、Xが複数存在する場合、それぞれ同一であっても異なっていてもよい。 In formula (A1), R 1 's are each independently a divalent organic group, R 2 's are each independently a divalent hydrocarbon group which may have a substituent, R 3 's are each independently a hydrogen atom or a methyl group, X is a divalent organic group, and n is an integer of 0 to 10. When there are a plurality of R 1's , R 2's , and R 3 's, they may be the same or different, and when there are a plurality of X's, they may be the same or different.
式(A1)中において、R1としては、例えば、2価の炭化水素基、エーテル結合及びエステル結合からなる群から選択される1つ以上の結合を含む2価の有機基が挙げられる。
R1としての2価の炭化水素基は、例えば、2価の鎖状炭化水素基、環構造(芳香環構造、脂環式構造)を含む2価の炭化水素基であってもよい。
R1としての2価の有機基がエーテル結合を含む場合、エーテル結合の数は、1~30が好ましく、1~20がより好ましく、1~15がさらに好ましい。
R1としての2価の有機基がエステル結合を含む場合、エステル結合の数は、1~12が好ましく、1~8がより好ましく、1~6がさらに好ましい。
式(A1)中において、R1の炭素数としては、例えば、2~60であってもよいが、2~40であることが好ましく、2~30であることがより好ましい。
In formula (A1), examples of R 1 include divalent organic groups containing one or more bonds selected from the group consisting of divalent hydrocarbon groups, ether bonds, and ester bonds.
The divalent hydrocarbon group represented by R 1 may be, for example, a divalent chain hydrocarbon group or a divalent hydrocarbon group containing a ring structure (aromatic ring structure, alicyclic structure).
When the divalent organic group represented by R 1 contains an ether bond, the number of the ether bonds is preferably 1 to 30, more preferably 1 to 20, and further preferably 1 to 15.
When the divalent organic group represented by R 1 contains an ester bond, the number of the ester bonds is preferably 1 to 12, more preferably 1 to 8, and further preferably 1 to 6.
In formula (A1), R 1 may have, for example, 2 to 60 carbon atoms, preferably 2 to 40 carbon atoms, and more preferably 2 to 30 carbon atoms.
式(A1)中において、R1は、以下の一般式(A1-R1)で表される基であることが好ましい。 In formula (A1), R 1 is preferably a group represented by the following general formula (A1-R 1 ).
一般式(A1-R1)中、R1Aは、置換基を有してもよい2価の炭化水素基であり、R1Bは、メチレン基(-CH2-)又はカルボニル基(-C(=O)-)であり、R1Cは2価の炭化水素基であり、mは0~10の整数である。R1B、R1Cが複数存在する場合、それぞれ同一であっても異なっていてもよい。*は結合位置を示す。 In general formula (A1-R 1 ), R 1A is a divalent hydrocarbon group which may have a substituent, R 1B is a methylene group (-CH 2 -) or a carbonyl group (-C(=O)-), R 1C is a divalent hydrocarbon group, and m is an integer of 0 to 10. When a plurality of R 1B and R 1C are present, they may be the same or different. * indicates a bonding position.
一般式(A1-R1)におけるR1Aとしての置換基を有してもよい2価の炭化水素基は、例えば、2価の鎖状炭化水素基、環構造を含む2価の炭化水素基であり、好ましくは2価の鎖状炭化水素基である。2価の炭化水素基に含まれる環構造は、芳香族構造であっても脂環式構造であってもよい。
R1Aとしての2価の鎖状炭化水素基は、分岐鎖状であってもよく、飽和でも不飽和でもよい。
R1Aとしての2価の鎖状炭化水素基の炭素数は、好ましくは2~20であり、より好ましくは2~15であり、さらに好ましくは2~10である。
R1Aとしての2価の鎖状炭化水素基が有してもよい置換基は、例えば、炭素数2~10のアルコキシ基、炭素数6~20のアリールオキシ基であり、好ましくはアリールオキシ基である。アリールオキシ基としては、例えば、フェノキシ基、ナフチルオキシ基等が挙げられるが、好ましくはフェノキシ基である。
R1Aとしての芳香族構造を含む2価の炭化水素基は、炭素数6~25(より好ましくは炭素数6~20、さらに好ましくは炭素数6~15)の芳香族構造を有する2価の炭化水素基であることが好ましい。芳香族構造を含む2価の炭化水素基が有してもよい置換基としては、炭素数1~6の直鎖又は分岐鎖アルキル基が挙げられる。
R1Aとしての脂環式構造を含む2価の炭化水素基は、炭素数3~20(より好ましくは炭素数6~12、さらに好ましくは炭素数6~8)の脂環式構造を有する2価の炭化水素基が好ましい。脂環式構造を含む2価の炭化水素基が有してもよい置換基としては、炭素数1~6の直鎖又は分岐鎖アルキル基が挙げられる。
The divalent hydrocarbon group which may have a substituent as R 1A in general formula (A1-R 1 ) is, for example, a divalent chain hydrocarbon group or a divalent hydrocarbon group containing a ring structure, preferably a divalent chain hydrocarbon group. The ring structure contained in the divalent hydrocarbon group may be an aromatic structure or an alicyclic structure.
The divalent chain hydrocarbon group represented by R 1A may be branched and may be saturated or unsaturated.
The divalent chain hydrocarbon group represented by R 1A preferably has 2 to 20 carbon atoms, more preferably 2 to 15 carbon atoms, and even more preferably 2 to 10 carbon atoms.
The substituent that the divalent chain hydrocarbon group represented by R 1A may have is, for example, an alkoxy group having 2 to 10 carbon atoms or an aryloxy group having 6 to 20 carbon atoms, preferably an aryloxy group. Examples of the aryloxy group include a phenoxy group and a naphthyloxy group, and the phenoxy group is preferred.
The divalent hydrocarbon group containing an aromatic structure represented by R 1A is preferably a divalent hydrocarbon group having an aromatic structure containing 6 to 25 carbon atoms (more preferably 6 to 20 carbon atoms, and even more preferably 6 to 15 carbon atoms). Examples of the substituent that the divalent hydrocarbon group containing an aromatic structure may have include a linear or branched alkyl group having 1 to 6 carbon atoms.
The divalent hydrocarbon group containing an alicyclic structure represented by R 1A is preferably a divalent hydrocarbon group having an alicyclic structure having 3 to 20 carbon atoms (more preferably 6 to 12 carbon atoms, and even more preferably 6 to 8 carbon atoms). Examples of the substituent that the divalent hydrocarbon group containing an alicyclic structure may have include a linear or branched alkyl group having 1 to 6 carbon atoms.
一般式(A1-R1)におけるR1Cとしての2価の炭化水素基としては、2価の鎖状炭化水素基、環構造(芳香族構造又は脂環式構造)を含む2価の炭化水素基が挙げられるが、2価の鎖状炭化水素基が好ましい。
R1Cとしての2価の鎖状炭化水素基の炭素数は、1~30であることが好ましく、1~20であることがより好ましく、1~10であることがさらに好ましい。
R1Cとしての芳香族構造を含む2価の炭化水素基は、炭素数6~25(より好ましくは炭素数6~20、さらに好ましくは炭素数6~15)の芳香族構造を有する2価の炭化水素基であることが好ましい。
R1Cとしての脂環式構造を含む2価の炭化水素基は、炭素数3~20(より好ましくは炭素数6~12、さらに好ましくは炭素数6~8)の脂環式構造を有する2価の炭化水素基が好ましい。
Examples of the divalent hydrocarbon group represented by R 1C in general formula (A1-R 1 ) include divalent chain hydrocarbon groups and divalent hydrocarbon groups containing a ring structure (aromatic structure or alicyclic structure), with a divalent chain hydrocarbon group being preferred.
The divalent chain hydrocarbon group represented by R 1C preferably has 1 to 30 carbon atoms, more preferably 1 to 20 carbon atoms, and even more preferably 1 to 10 carbon atoms.
The divalent hydrocarbon group having an aromatic structure represented by R 1C is preferably a divalent hydrocarbon group having an aromatic structure having 6 to 25 carbon atoms (more preferably 6 to 20 carbon atoms, and even more preferably 6 to 15 carbon atoms).
The divalent hydrocarbon group containing an alicyclic structure as R 1C is preferably a divalent hydrocarbon group having an alicyclic structure having 3 to 20 carbon atoms (more preferably 6 to 12 carbon atoms, and even more preferably 6 to 8 carbon atoms).
一般式(A1-R1)におけるmは、0~10の整数であり、好ましくは0~8であり、より好ましくは0~6である。 In formula (A1-R 1 ), m is an integer of 0 to 10, preferably 0 to 8, and more preferably 0 to 6.
一般式(A1-R1)における左側の*(すなわち、R1Aからの結合位置)は、一般式(A1)におけるR1の左側にある酸素原子と結合することが好ましく、右側の*(すなわち、R1Cからの結合位置)は、一般式(A1)におけるR1の右側にある酸素原子と結合することが好ましい。 In general formula (A1-R 1 ), the * on the left side (i.e., the bonding position from R 1A ) preferably bonds to the oxygen atom on the left side of R 1 in general formula (A1), and the * on the right side (i.e., the bonding position from R 1C ) preferably bonds to the oxygen atom on the right side of R 1 in general formula (A1).
式(A1)中において、R2としての2価の炭化水素基は、例えば、2価の鎖状炭化水素基、環構造を含む2価の炭化水素基である。
R2としての2価の鎖状炭化水素基の炭素数は、1~25が好ましく、1~20がより好ましく、2~15がさらに好ましい。
R2としての環構造を含む2価の炭化水素基は、芳香族構造を含んでもよい、脂環式構造を含んでもよい。
R2としての芳香族構造を含む2価の炭化水素基の炭素数は、6~25が好ましく、6~20がより好ましく、6~15がさらに好ましい。
R2としての脂環式構造を含む2価の炭化水素基の炭素数は、3~20が好ましく、6~15がより好ましく、6~10がさらに好ましい。
In formula (A1), the divalent hydrocarbon group represented by R 2 is, for example, a divalent chain hydrocarbon group or a divalent hydrocarbon group containing a ring structure.
The divalent chain hydrocarbon group represented by R2 preferably has 1 to 25 carbon atoms, more preferably has 1 to 20 carbon atoms, and even more preferably has 2 to 15 carbon atoms.
The divalent hydrocarbon group containing a ring structure represented by R2 may contain an aromatic structure or an alicyclic structure.
The divalent hydrocarbon group containing an aromatic structure represented by R2 preferably has 6 to 25 carbon atoms, more preferably 6 to 20 carbon atoms, and even more preferably 6 to 15 carbon atoms.
The divalent hydrocarbon group containing an alicyclic structure represented by R2 preferably has 3 to 20 carbon atoms, more preferably 6 to 15 carbon atoms, and even more preferably 6 to 10 carbon atoms.
R2としての2価の炭化水素基は、具体的には以下の一般式(A1-R2-1)~一般式(A1-R2-13)から選択される構造で表される2価の炭化水素基が好ましい。 Specifically, the divalent hydrocarbon group represented by R 2 is preferably a divalent hydrocarbon group represented by a structure selected from the following general formulae (A1-R 2 -1) to (A1-R 2 -13).
一般式(A1-R2-1)~一般式(A1-R2-13)中、*は結合位置を示す。 In the general formulae (A1-R 2 -1) to (A1-R 2 -13), * indicates the bonding position.
式(A1)中において、Xは2価の有機基であり、好ましくは、エーテル結合及びエステル結合からなる群から選択される1つ以上の結合を含む2価の有機基である。
Xとしての2価の有機基がエーテル結合を含む場合、エーテル結合の数は、好ましくは1~100であり、より好ましくは2~90であり、さらに好ましくは4~80である。
Xとしての2価の有機基がエステル結合を含む場合、エステル結合の数は、好ましくは1~100であり、より好ましくは2~90であり、さらに好ましくは4~80である。
Xとしての2価の有機基の炭素数は、好ましくは2~500であり、より好ましくは2~400であり、さらに好ましくは2~300である。
In formula (A1), X is a divalent organic group, and is preferably a divalent organic group containing one or more bonds selected from the group consisting of ether bonds and ester bonds.
When the divalent organic group represented by X contains an ether bond, the number of the ether bonds is preferably 1 to 100, more preferably 2 to 90, and further preferably 4 to 80.
When the divalent organic group represented by X contains an ester bond, the number of ester bonds is preferably 1 to 100, more preferably 2 to 90, and further preferably 4 to 80.
The divalent organic group represented by X preferably has 2 to 500 carbon atoms, more preferably 2 to 400 carbon atoms, and even more preferably 2 to 300 carbon atoms.
式(A1)中におけるXは、好ましくは以下の一般式(A1-X)で表される基である。 In formula (A1), X is preferably a group represented by the following general formula (A1-X):
一般式(A1-X)中、RXAは、2価の炭化水素基であり、RXBは、メチレン基(-CH2-)又はカルボニル基(-C(=O)-)であり、RXCは2価の炭化水素基であり、kは0~100の整数である。RXB、RXCが複数存在する場合、それぞれ同一であっても異なっていてもよい。*は結合位置を示す。 In general formula (A1-X), R XA is a divalent hydrocarbon group, R XB is a methylene group (-CH 2 -) or a carbonyl group (-C(=O)-), R XC is a divalent hydrocarbon group, and k is an integer of 0 to 100. When a plurality of R XB and R XC are present, they may be the same or different. * indicates a bonding position.
一般式(A1-X)におけるRXAとしての2価の炭化水素基は、例えば、2価の鎖状炭化水素基、環構造を含む2価の炭化水素基であり、好ましくは2価の鎖状炭化水素基である。2価の炭化水素基に含まれる環構造は、芳香族構造であっても脂環式構造であってもよい。
RXAとしての2価の鎖状炭化水素基は、分岐鎖状であってもよく、飽和でも不飽和でもよい。
RXAとしての2価の鎖状炭化水素基の炭素数は、好ましくは2~20であり、より好ましくは2~15であり、さらに好ましくは2~10である。
RXAとしての芳香族構造を含む2価の炭化水素基は、炭素数6~25(より好ましくは炭素数6~20、さらに好ましくは炭素数6~15)の芳香族構造を有する2価の炭化水素基であることが好ましい。
RXAとしての脂環式構造を含む2価の炭化水素基は、炭素数3~20(より好ましくは炭素数6~12、さらに好ましくは炭素数6~8)の脂環式構造を有する2価の炭化水素基が好ましい。
The divalent hydrocarbon group represented by R XA in general formula (A1-X) is, for example, a divalent chain hydrocarbon group or a divalent hydrocarbon group containing a ring structure, and is preferably a divalent chain hydrocarbon group. The ring structure contained in the divalent hydrocarbon group may be an aromatic structure or an alicyclic structure.
The divalent chain hydrocarbon group represented by R 1 XA may be branched and may be saturated or unsaturated.
The divalent chain hydrocarbon group represented by R 1 XA preferably has 2 to 20 carbon atoms, more preferably 2 to 15 carbon atoms, and even more preferably 2 to 10 carbon atoms.
The divalent hydrocarbon group containing an aromatic structure as R XA is preferably a divalent hydrocarbon group having an aromatic structure having 6 to 25 carbon atoms (more preferably 6 to 20 carbon atoms, and even more preferably 6 to 15 carbon atoms).
The divalent hydrocarbon group containing an alicyclic structure as R XA is preferably a divalent hydrocarbon group having an alicyclic structure having 3 to 20 carbon atoms (more preferably 6 to 12 carbon atoms, and even more preferably 6 to 8 carbon atoms).
一般式(A1-X)におけるRXCとしての2価の炭化水素基としては、2価の鎖状炭化水素基、環構造を含む2価の炭化水素基が挙げられるが、2価の鎖状炭化水素基が好ましい。
RXCとしての2価の鎖状炭化水素基の炭素数は、1~30であることが好ましく、1~20であることがより好ましく、1~10であることがさらに好ましい。
RXCとしての芳香族構造を含む2価の炭化水素基は、炭素数6~25(より好ましくは炭素数6~20、さらに好ましくは炭素数6~15)の芳香族構造を有する2価の炭化水素基であることが好ましい。
RXCとしての脂環式構造を含む2価の炭化水素基は、炭素数3~20(より好ましくは炭素数6~12、さらに好ましくは炭素数6~8)の脂環式構造を有する2価の炭化水素基が好ましい。
Examples of the divalent hydrocarbon group represented by R 3 XC in general formula (A1-X) include divalent chain hydrocarbon groups and divalent hydrocarbon groups containing a ring structure, with a divalent chain hydrocarbon group being preferred.
The divalent chain hydrocarbon group represented by R 3 XC preferably has 1 to 30 carbon atoms, more preferably 1 to 20 carbon atoms, and even more preferably 1 to 10 carbon atoms.
The divalent hydrocarbon group containing an aromatic structure as R XC is preferably a divalent hydrocarbon group having an aromatic structure having 6 to 25 carbon atoms (more preferably 6 to 20 carbon atoms, and even more preferably 6 to 15 carbon atoms).
The divalent hydrocarbon group containing an alicyclic structure as R 3 XC is preferably a divalent hydrocarbon group having an alicyclic structure having 3 to 20 carbon atoms (more preferably 6 to 12 carbon atoms, and even more preferably 6 to 8 carbon atoms).
一般式(A1-X)におけるkは、0~100であり、好ましくは2~90であり、より好ましくは4~80である。 In general formula (A1-X), k is 0 to 100, preferably 2 to 90, and more preferably 4 to 80.
(メタ)アクリルモノマー(A)の含有量は、(メタ)アクリルモノマー成分の全量に対し、5質量%~60質量%であることが好ましく、10質量%~50質量%であることがより好ましく、15質量%~45質量%であることがさらに好ましい。 The content of (meth)acrylic monomer (A) is preferably 5% by mass to 60% by mass, more preferably 10% by mass to 50% by mass, and even more preferably 15% by mass to 45% by mass, based on the total amount of (meth)acrylic monomer components.
((メタ)アクリルモノマー(B))
(メタ)アクリルモノマー(B)は、2つの(メタ)アクリロイルオキシ基を含み、分子量が170以上1000未満である。
光重合性成分が(メタ)アクリルモノマー(B)を含むことで、得られる硬化物における硬さを向上させることができ(すなわち、37℃での貯蔵弾性率の数値を上げるように調整でき)、反応性にも優れる。
((Meth)acrylic monomer (B))
The (meth)acrylic monomer (B) contains two (meth)acryloyloxy groups and has a molecular weight of 170 or more and less than 1,000.
When the photopolymerizable component contains the (meth)acrylic monomer (B), the hardness of the obtained cured product can be improved (i.e., the storage modulus at 37°C can be adjusted to be increased), and the reactivity is also excellent.
(メタ)アクリルモノマー(B)は環状構造を含むことが好ましい。
(メタ)アクリルモノマー(B)に含まれる環状構造における環の数は、1つのみであってもよいし2つ以上であってもよい。
(メタ)アクリルモノマー(B)に含まれる環状構造は、芳香環構造及び脂環構造のいずれであっても両方であってもよいが、芳香環構造を含むことが好ましい。
(メタ)アクリルモノマー(B)に含まれる環状構造は、ビスフェノールA構造が特に好ましい。
(メタ)アクリルモノマー(B)は、2つのウレタン結合を含むことが特に好ましく、例えば以下の一般式(B1)で表される化合物(以下、「(メタ)アクリルモノマー(B1)」ともいう。)が好ましい。
The (meth)acrylic monomer (B) preferably contains a cyclic structure.
The number of rings in the cyclic structure contained in the (meth)acrylic monomer (B) may be only one, or may be two or more.
The cyclic structure contained in the (meth)acrylic monomer (B) may be either an aromatic ring structure or an alicyclic structure, or both, but preferably contains an aromatic ring structure.
The cyclic structure contained in the (meth)acrylic monomer (B) is particularly preferably a bisphenol A structure.
It is particularly preferable that the (meth)acrylic monomer (B) contains two urethane bonds, and for example, a compound represented by the following general formula (B1) (hereinafter also referred to as "(meth)acrylic monomer (B1)") is preferable.
式(B1)中、R1は、それぞれ独立に2価の有機基であり、R2はそれぞれ独立に置換基を有していてもよい2価の炭化水素基であり、R3は、それぞれ独立に水素原子又はメチル基である。複数存在するR1、R3は、それぞれ同一であっても異なっていてもよい。 In formula (B1), R1 is independently a divalent organic group, R2 is independently a divalent hydrocarbon group which may have a substituent, and R3 is independently a hydrogen atom or a methyl group. A plurality of R1s and R3s may be the same or different.
R1としては、例えば、2価の炭化水素基及びエーテル結合からなる群から選択される1つ以上の結合を含む2価の有機基が挙げられる。
R1としての2価の炭化水素基は、例えば、2価の鎖状炭化水素基、環構造(芳香環構造、脂環式構造)を含む2価の炭化水素基であることが好ましい。
R1としての2価の有機基がエーテル結合を含む場合、エーテル結合の数は、1~2がさらに好ましい。
Examples of R 1 include divalent organic groups containing one or more bonds selected from the group consisting of divalent hydrocarbon groups and ether bonds.
The divalent hydrocarbon group represented by R 1 is preferably, for example, a divalent chain hydrocarbon group or a divalent hydrocarbon group containing a ring structure (aromatic ring structure, alicyclic structure).
When the divalent organic group represented by R 1 contains an ether bond, the number of the ether bonds is more preferably 1 to 2.
式(B1)中において、R1の炭素数としては、例えば、2~30であってもよいが、2~20であることが好ましく、2~10であることがより好ましい。
R1としては、置換基を有してもよい炭素数2~6のアルキレン基が好ましく、置換基としてはアリールオキシ基(例えば、フェノキシ基)が好ましい。
本開示の光硬化性組成物は、(メタ)アクリルモノマー(B)として、(メタ)アクリルモノマー(B1)を含む場合、さらに、(メタ)アクリルモノマー(B)として、ウレタン結合及び環構造を有さない(メタ)アクリルモノマー(B2)を含んでもよい。
In formula (B1), R 1 may have, for example, 2 to 30 carbon atoms, preferably 2 to 20 carbon atoms, and more preferably 2 to 10 carbon atoms.
R 1 is preferably an alkylene group having 2 to 6 carbon atoms which may have a substituent, and the substituent is preferably an aryloxy group (for example, a phenoxy group).
When the photocurable composition of the present disclosure contains the (meth)acrylic monomer (B1) as the (meth)acrylic monomer (B), the (meth)acrylic monomer (B) may further contain a (meth)acrylic monomer (B2) having neither a urethane bond nor a ring structure.
(メタ)アクリルモノマー(B)の分子量は、170以上1000未満であり、好ましくは200以上800以下であり、より好ましくは300以上700以下である。 The molecular weight of the (meth)acrylic monomer (B) is 170 or more and less than 1,000, preferably 200 or more and 800 or less, and more preferably 300 or more and 700 or less.
(メタ)アクリルモノマー(B)としては、エトキシ化ビスフェノールAジアクリレート、ウレタンジ(メタ)アクリレート、テトラエチレングリコールジアクリレート、ノナンプロピレングリコールジメタクリレート等が挙げられる。このうち、(メタ)アクリルモノマー(B2)は、テトラエチレングリコールジアクリレート、ノナンプロピレングリコールジメタクリレート、プロポキシ化(2)ネオペンチルグリコールジアクリレート等が挙げられる。 (Meth)acrylic monomers (B) include ethoxylated bisphenol A diacrylate, urethane di(meth)acrylate, tetraethylene glycol diacrylate, nonanepropylene glycol dimethacrylate, etc. Among these, (meth)acrylic monomers (B2) include tetraethylene glycol diacrylate, nonanepropylene glycol dimethacrylate, propoxylated (2) neopentyl glycol diacrylate, etc.
(メタ)アクリルモノマー(B)の含有量が、(メタ)アクリルモノマー成分の全量に対し、15質量%~80質量%であることが好ましく、20質量%~70質量%であることがより好ましく、25質量%~60質量%であることがさらに好ましい。
このうち、(メタ)アクリルモノマー(B1)と(メタ)アクリルモノマー(B2)が本開示の光硬化性組成物に含まれる場合、(メタ)アクリルモノマー(B1)の含有量が、(メタ)アクリルモノマー成分の全量に対し、10質量%~60質量%であることが好ましく、15質量%~50質量%であることがより好ましく、20質量%~45質量%であることがさらに好ましく、(メタ)アクリルモノマー(B2)の含有量が、(メタ)アクリルモノマー成分の全量に対し、0.1質量%~20質量%であることが好ましく、1質量%~20質量%であることがより好ましく、1.5質量%~10質量%であることがさらに好ましい。
The content of the (meth)acrylic monomer (B) is preferably 15% by mass to 80% by mass, more preferably 20% by mass to 70% by mass, and even more preferably 25% by mass to 60% by mass, based on the total amount of the (meth)acrylic monomer components.
Among these, when the (meth)acrylic monomer (B1) and the (meth)acrylic monomer (B2) are contained in the photocurable composition of the present disclosure, the content of the (meth)acrylic monomer (B1) is preferably 10% by mass to 60% by mass, more preferably 15% by mass to 50% by mass, and even more preferably 20% by mass to 45% by mass, relative to the total amount of the (meth)acrylic monomer components, and the content of the (meth)acrylic monomer (B2) is preferably 0.1% by mass to 20% by mass, more preferably 1% by mass to 20% by mass, and even more preferably 1.5% by mass to 10% by mass, relative to the total amount of the (meth)acrylic monomer components.
((メタ)アクリルモノマー(C))
(メタ)アクリルモノマー(C)は、1つの(メタ)アクリロイルオキシ基を含み、芳香環構造を含む。
光重合性成分が(メタ)アクリルモノマー(C)を含むことで、得られる硬化物における柔らかさを向上させることができ(すなわち、37℃での貯蔵弾性率の数値を下げるように調整でき)、反応性が過剰となることを抑制することができる。また、(メタ)アクリルモノマー(C)は希釈剤として用いてもよい。
((Meth)acrylic monomer (C))
The (meth)acrylic monomer (C) contains one (meth)acryloyloxy group and contains an aromatic ring structure.
By including the (meth)acrylic monomer (C) in the photopolymerizable component, the softness of the obtained cured product can be improved (i.e., the storage modulus at 37° C. can be adjusted to be lower), and excessive reactivity can be suppressed. The (meth)acrylic monomer (C) may also be used as a diluent.
(メタ)アクリルモノマー(C)は芳香環構造を有する。
(メタ)アクリルモノマー(C)に含まれる芳香環構造の数は、1つのみであってもよいし2つ以上であってもよい。
(メタ)アクリルモノマー(C)に含まれる芳香環構造は、ベンゼン環が特に好ましい。
The (meth)acrylic monomer (C) has an aromatic ring structure.
The number of aromatic ring structures contained in the (meth)acrylic monomer (C) may be only one, or may be two or more.
The aromatic ring structure contained in the (meth)acrylic monomer (C) is particularly preferably a benzene ring.
(メタ)アクリルモノマー(C)の分子量は、140~500であることが好ましく、150~400であることがより好ましく、170~300であることがさらに好ましい。
(メタ)アクリルモノマー(C)は、例えば、以下の式(C1)で表される化合物であってもよい。
The molecular weight of the (meth)acrylic monomer (C) is preferably 140-500, more preferably 150-400, and even more preferably 170-300.
The (meth)acrylic monomer (C) may be, for example, a compound represented by the following formula (C1):
式(C1)中、R1は芳香環を有する1価の有機基であり、R2は水素原子又はメチル基である。 In formula (C1), R 1 is a monovalent organic group having an aromatic ring, and R 2 is a hydrogen atom or a methyl group.
式(C1)中におけるR1は、炭素数6~30であることが好ましく、炭素数6~20であることがより好ましい。 In formula (C1), R 1 preferably has 6 to 30 carbon atoms, and more preferably has 6 to 20 carbon atoms.
式(C1)中におけるR1としての1価の有機基が有する芳香環が1つ以上であればよいが、芳香環が1つ又は2つであることが好ましい。
式(C1)中におけるR1としての1価の有機基が有する芳香環は、単環であってもよく、多環であってもよい。
単環の芳香環としては、例えば、フェニル構造(フェニル基、フェニレン基)が挙げられる。単環の芳香環は、置換基を有してもよく、置換基としては、アルキル基、アリールオキシ基(フェノキシ基等)、アリールアルキレン基、アリール基が挙げられる。
多環の芳香環としては、例えば、ナフチル構造(ナフチル基、ナフチレン基)が挙げられる。多環の芳香環は、置換基を有してもよく、置換基としては、アルキル基、アリールオキシ基(フェノキシ基等)、アリールアルキレン基、アリール基が挙げられる。
The monovalent organic group represented by R 1 in formula (C1) may have one or more aromatic rings, and preferably has one or two aromatic rings.
The aromatic ring contained in the monovalent organic group represented by R 1 in formula (C1) may be a monocyclic ring or a polycyclic ring.
Examples of the monocyclic aromatic ring include a phenyl structure (phenyl group, phenylene group). The monocyclic aromatic ring may have a substituent, and examples of the substituent include an alkyl group, an aryloxy group (e.g., a phenoxy group), an arylalkylene group, and an aryl group.
Examples of the polycyclic aromatic ring include a naphthyl structure (a naphthyl group, a naphthylene group). The polycyclic aromatic ring may have a substituent, and examples of the substituent include an alkyl group, an aryloxy group (such as a phenoxy group), an arylalkylene group, and an aryl group.
R1は、以下の一般式(C1-R1-1)~一般式(C1-R1-7)から選択される構造で表される1価の有機基であることが好ましい。 R 1 is preferably a monovalent organic group represented by a structure selected from the following general formulae (C1-R 1 -1) to (C1-R 1 -7).
一般式(C1-R1-1)~一般式(C1-R1-7)中、*は結合位置を示す。
一般式(C1-R1-7)中、R1Aは、炭素数1~10のアルキル基を示す。
In the general formulae (C1-R 1 -1) to (C1-R 1 -7), * indicates the bonding position.
In general formula (C1-R 1 -7), R 1A represents an alkyl group having 1 to 10 carbon atoms.
(メタ)アクリルモノマー(C)としては、ベンジルメタクリレート、フェノキシエチルメタクリレート、フェノキシエチルアクリレート、m-フェノキシベンジルアクリレート、2-(o-フェニルフェノキシ)エチルアクリレート、2-ヒドロキシ-3-フェノキシプロピルアクリレート等が挙げられる。 Examples of (meth)acrylic monomers (C) include benzyl methacrylate, phenoxyethyl methacrylate, phenoxyethyl acrylate, m-phenoxybenzyl acrylate, 2-(o-phenylphenoxy)ethyl acrylate, 2-hydroxy-3-phenoxypropyl acrylate, etc.
(メタ)アクリルモノマー(C)の含有量が、(メタ)アクリルモノマー成分の全量に対し、5質量%~70質量%であることが好ましい。
(メタ)アクリルモノマー(C)の含有量が、(メタ)アクリルモノマー成分の全量に対し、70質量%以下であることで、反応性に優れる。これによって、造形性に優れ、粘度上昇を抑制することができる。
上記の観点から、(メタ)アクリルモノマー(C)の含有量が、(メタ)アクリルモノマー成分の全量に対し、60質量%以下であることがより好ましく、50質量%以下であることがさらに好ましい。
(メタ)アクリルモノマー(C)の含有量が、(メタ)アクリルモノマー成分の全量に対し、5質量%以上であることで、過剰な反応性を抑制できる。
上記の観点から、(メタ)アクリルモノマー(C)の含有量が、(メタ)アクリルモノマー成分の全量に対し、10質量%以上であることがより好ましい。
The content of the (meth)acrylic monomer (C) is preferably 5% by mass to 70% by mass based on the total amount of the (meth)acrylic monomer components.
When the content of the (meth)acrylic monomer (C) is 70 mass% or less based on the total amount of the (meth)acrylic monomer components, the reactivity is excellent, and thus the moldability is excellent and an increase in viscosity can be suppressed.
From the above viewpoints, the content of the (meth)acrylic monomer (C) is more preferably 60% by mass or less, and even more preferably 50% by mass or less, based on the total amount of the (meth)acrylic monomer components.
When the content of the (meth)acrylic monomer (C) is 5 mass % or more based on the total amount of the (meth)acrylic monomer components, excessive reactivity can be suppressed.
From the above viewpoint, the content of the (meth)acrylic monomer (C) is more preferably 10 mass % or more based on the total amount of the (meth)acrylic monomer components.
(他の(メタ)アクリルモノマー)
光重合性成分は、上述した、(メタ)アクリルモノマー(A)、(メタ)アクリルモノマー(B)、及び(メタ)アクリルモノマー(C)以外の他の(メタ)アクリルモノマーを含んでいてもよい。
(Other (meth)acrylic monomers)
The photopolymerizable component may contain a (meth)acrylic monomer other than the above-mentioned (meth)acrylic monomer (A), (meth)acrylic monomer (B), and (meth)acrylic monomer (C).
他の(メタ)アクリルモノマーの分子量は、好ましくは80~600であり、より好ましくは100~400であり、さらに好ましくは140~250である。 The molecular weight of the other (meth)acrylic monomer is preferably 80 to 600, more preferably 100 to 400, and even more preferably 140 to 250.
他の(メタ)アクリルモノマーとしては、1つの(メタ)アクリロイルオキシ基を有する(メタ)アクリルモノマーが好ましい。
他の(メタ)アクリルモノマーとしては、芳香環構造を有さない(メタ)アクリルモノマーも好ましい。
As the other (meth)acrylic monomer, a (meth)acrylic monomer having one (meth)acryloyloxy group is preferred.
As the other (meth)acrylic monomer, a (meth)acrylic monomer having no aromatic ring structure is also preferred.
他の(メタ)アクリルモノマーとしては、1つの(メタ)アクリロイルオキシ基を含み、芳香環構造を有さない(メタ)アクリルモノマー(D)がより好ましい。
光重合性成分が(メタ)アクリルモノマー(D)を含むことで、光硬化性組成物の粘度上昇を抑制して、光硬化性組成物の粘度を容易に調整することができる。
この場合において、(メタ)アクリルモノマー(C)と(メタ)アクリルモノマー(D)とを併用することで、得られる硬化物における柔らかさを向上させる効果も得ることができる。
As the other (meth)acrylic monomer, a (meth)acrylic monomer (D) containing one (meth)acryloyloxy group and having no aromatic ring structure is more preferable.
When the photopolymerizable component contains the (meth)acrylic monomer (D), an increase in the viscosity of the photocurable composition can be suppressed, and the viscosity of the photocurable composition can be easily adjusted.
In this case, by using the (meth)acrylic monomer (C) and the (meth)acrylic monomer (D) in combination, the effect of improving the softness of the resulting cured product can be obtained.
(メタ)アクリルモノマー(D)の分子量は、120~400であることが好ましく、1300~350であることがより好ましく、140~300であることがさらに好ましい。 The molecular weight of the (meth)acrylic monomer (D) is preferably 120 to 400, more preferably 1300 to 350, and even more preferably 140 to 300.
(メタ)アクリルモノマー(D)の含有量が、(メタ)アクリルモノマー成分の全量に対し、0質量%~30質量%であることが好ましく、1質量%~30質量%であることがより好ましく、5質量%~25質量%であることがより好ましく、10質量%~23%質量%であることがより好ましい。
(メタ)アクリルモノマー(D)の含有量が、(メタ)アクリルモノマー成分の全量に対し、30質量%以下(好ましくは25質量%以下)であることで、反応性に優れる。これによって、造形性に優れ、粘度上昇を抑制することができる。
(メタ)アクリルモノマー(D)の含有量が、(メタ)アクリルモノマー成分の全量に対し、5質量%以上であることで、粘度の上昇を抑制しつつ、過剰な反応性を抑制できる。
The content of the (meth)acrylic monomer (D) is preferably 0% by mass to 30% by mass, more preferably 1% by mass to 30% by mass, more preferably 5% by mass to 25% by mass, and still more preferably 10% by mass to 23% by mass, based on the total amount of the (meth)acrylic monomer components.
When the content of the (meth)acrylic monomer (D) is 30% by mass or less (preferably 25% by mass or less) based on the total amount of the (meth)acrylic monomer components, the reactivity is excellent. This makes it possible to provide excellent moldability and suppress an increase in viscosity.
When the content of the (meth)acrylic monomer (D) is 5% by mass or more based on the total amount of the (meth)acrylic monomer components, an increase in viscosity can be suppressed and excessive reactivity can be suppressed.
(メタ)アクリルモノマー(D)としては、ターシャリーブチル(メタ)アクリレート、シクロヘキシル(メタ)アクリレート、イソボルニル(メタ)アクリレート、テトラヒドロフルフリル(メタ)アクリレート等が挙げられる。 Examples of (meth)acrylic monomers (D) include tertiary butyl (meth)acrylate, cyclohexyl (meth)acrylate, isobornyl (meth)acrylate, and tetrahydrofurfuryl (meth)acrylate.
本開示の光硬化性組成物において、(メタ)アクリルモノマー(A)及び(メタ)アクリルモノマー(B)は、含有量が多い方が反応性を向上させて造形性を向上させることに寄与し、含有量が少ない方が粘度を低く調整することに寄与する。この観点で、(メタ)アクリルモノマー(A)及び(メタ)アクリルモノマー(B)の総含有量は、(メタ)アクリルモノマー成分の全量(即ち、光硬化性組成物に含有される全ての(メタ)アクリルモノマーの総含有量)に対し、20質量%~95質量%であることが好ましい。 In the photocurable composition of the present disclosure, a higher content of (meth)acrylic monomer (A) and (meth)acrylic monomer (B) contributes to improving reactivity and improving formability, while a lower content contributes to adjusting the viscosity lower. From this perspective, the total content of (meth)acrylic monomer (A) and (meth)acrylic monomer (B) is preferably 20% by mass to 95% by mass with respect to the total amount of (meth)acrylic monomer components (i.e., the total content of all (meth)acrylic monomers contained in the photocurable composition).
本開示の光硬化性組成物において、(メタ)アクリルモノマー(A)、(メタ)アクリルモノマー(B)、及び(メタ)アクリルモノマー(C)の総含有量は、(メタ)アクリルモノマー成分の全量(即ち、光硬化性組成物に含有される全ての(メタ)アクリルモノマーの総含有量)に対し、好ましくは50質量%以上であり、より好ましくは65質量%以上であり、さらに好ましくは80質量%以上であり、特に好ましくは90質量%以上である。
上記総含有量は、100質量%であってもよいし、100質量%未満(例えば、95質量%以下、90質量%以下、等)であってもよい。
In the photocurable composition of the present disclosure, the total content of the (meth)acrylic monomer (A), the (meth)acrylic monomer (B), and the (meth)acrylic monomer (C) is preferably 50 mass% or more, more preferably 65 mass% or more, even more preferably 80 mass% or more, and particularly preferably 90 mass% or more, based on the total amount of the (meth)acrylic monomer components (i.e., the total content of all the (meth)acrylic monomers contained in the photocurable composition).
The total content may be 100% by mass or less than 100% by mass (for example, 95% by mass or less, 90% by mass or less, etc.).
本開示の光硬化性組成物において、(メタ)アクリルモノマー(A)、(メタ)アクリルモノマー(B)、(メタ)アクリルモノマー(C)及び(メタ)アクリルモノマー(D)の総含有量は、(メタ)アクリルモノマー成分の全量(即ち、光硬化性組成物に含有される全ての(メタ)アクリルモノマーの総含有量)に対し、好ましくは60質量%以上であり、より好ましくは80質量%以上であり、さらに好ましくは90質量%以上であり、特に好ましくは95質量%以上である。
上記総含有量は、100質量%であってもよいし、100質量%未満(例えば、95質量%以下、90質量%以下等)であってもよい。
In the photocurable composition of the present disclosure, the total content of the (meth)acrylic monomer (A), the (meth)acrylic monomer (B), the (meth)acrylic monomer (C) and the (meth)acrylic monomer (D) is preferably 60 mass% or more, more preferably 80 mass% or more, even more preferably 90 mass% or more, and particularly preferably 95 mass% or more, based on the total amount of the (meth)acrylic monomer components (i.e., the total content of all the (meth)acrylic monomers contained in the photocurable composition).
The total content may be 100% by mass or less than 100% by mass (for example, 95% by mass or less, 90% by mass or less, etc.).
本開示の光硬化性組成物において、(メタ)アクリルモノマー(A)、(メタ)アクリルモノマー(B)、(メタ)アクリルモノマー(C)及び(メタ)アクリルモノマー(D)の総含有量は、光重合性成分の全量に対し、好ましくは60質量%以上であり、より好ましくは80質量%以上であり、さらに好ましくは90質量%以上であり、特に好ましくは95質量%以上である。
上記総含有量は、100質量%であってもよいし、100質量%未満(例えば、95質量%以下、90質量%以下等)であってもよい。
In the photocurable composition of the present disclosure, the total content of the (meth)acrylic monomer (A), the (meth)acrylic monomer (B), the (meth)acrylic monomer (C) and the (meth)acrylic monomer (D) is preferably 60 mass% or more, more preferably 80 mass% or more, even more preferably 90 mass% or more, and particularly preferably 95 mass% or more, based on the total amount of the photopolymerizable components.
The total content may be 100% by mass or less than 100% by mass (for example, 95% by mass or less, 90% by mass or less, etc.).
光重合性成分において、アクリロイル基とメタクリロイル基との合計含有量(mol/g)に対するメタクリロイル基の含有量(mol/g)が、0%~90%であることが好ましい。
アクリロイル基とメタクリロイル基との合計含有量(mol/g)に対するメタクリロイル基の含有量(mol/g)が、90%以下であることで反応性に優れ、造形性が向上する。
上記の観点から、アクリロイル基とメタクリロイル基との合計含有量(mol/g)に対するメタクリロイル基の含有量(mol/g)が、70%以下であることがより好ましく、50%以下であることがさらに好ましく、40%以下であることが特に好ましい。
アクリロイル基とメタクリロイル基との合計含有量(mol/g)に対するメタクリロイル基の含有量(mol/g)が、0%以上(特に、0%超)であることで得られる硬化物の硬さに優れる。
上記の観点から、アクリロイル基とメタクリロイル基との合計含有量(mol/g)に対するメタクリロイル基の含有量(mol/g)が、3%以上であることがより好ましく、5%以上であることがさらに好ましく、10%以上であることが特に好ましい。
In the photopolymerizable component, the content (mol/g) of methacryloyl groups relative to the total content (mol/g) of acryloyl groups and methacryloyl groups is preferably 0% to 90%.
When the content (mol/g) of methacryloyl groups relative to the total content (mol/g) of acryloyl groups and methacryloyl groups is 90% or less, excellent reactivity and improved moldability are achieved.
From the above viewpoint, the content (mol/g) of methacryloyl groups relative to the total content (mol/g) of acryloyl groups and methacryloyl groups is more preferably 70% or less, even more preferably 50% or less, and particularly preferably 40% or less.
When the content (mol/g) of methacryloyl groups relative to the total content (mol/g) of acryloyl groups and methacryloyl groups is 0% or more (particularly, more than 0%), the hardness of the obtained cured product is excellent.
From the above viewpoints, the content (mol/g) of methacryloyl groups relative to the total content (mol/g) of acryloyl groups and methacryloyl groups is more preferably 3% or more, even more preferably 5% or more, and particularly preferably 10% or more.
<光重合開始剤>
本開示の光硬化性組成物は、光重合開始剤を含有する。
光重合開始剤としては、例えば、アルキルフェノン化合物、アシルホスフィンオキサイド化合物、チタノセン化合物、オキシムエステル化合物、ベンゾイン化合物、アセトフェノン化合物、ベンゾフェノン化合物、チオキサントン化合物、α-アシロキシムエステル化合物、フェニルグリオキシレート化合物、ベンジル化合物、アゾ化合物、ジフェニルスルフィド化合物、鉄-フタロシアニン化合物、ベンソインエーテル化合物、アントラキノン化合物等が挙げられる。
<Photopolymerization initiator>
The photocurable composition of the present disclosure contains a photopolymerization initiator.
Examples of the photopolymerization initiator include alkylphenone compounds, acylphosphine oxide compounds, titanocene compounds, oxime ester compounds, benzoin compounds, acetophenone compounds, benzophenone compounds, thioxanthone compounds, α-acyloxime ester compounds, phenylglyoxylate compounds, benzyl compounds, azo compounds, diphenyl sulfide compounds, iron-phthalocyanine compounds, benzoin ether compounds, and anthraquinone compounds.
反応性の観点からは、光重合開始剤は、アルキルフェノン化合物及びアシルホスフィンオキサイド化合物からなる群より選択される少なくとも1種を含むことが好ましい。
得られる硬化物の透明性(つまりΔE*
abを低く抑える)の観点からは、アシルホスフィンオキサイド化合物を含むことが好ましい。
立体造形物の造形精度を向上させる観点から、光重合開始剤は、
アシルホスフィンオキサイド化合物(例えば、2,4,6-トリメチルベンゾイル-ジフェニル-ホスフィンオキサイド、ビス(2,4,6-トリメチルベンゾイル)フェニルホスフィンオキサイド、等)を含むことが好ましく、
2,4,6-トリメチルベンゾイル-ジフェニル-ホスフィンオキサイドを含むことがより好ましい。
From the viewpoint of reactivity, the photopolymerization initiator preferably contains at least one selected from the group consisting of alkylphenone compounds and acylphosphine oxide compounds.
From the viewpoint of transparency of the obtained cured product (that is, keeping ΔE * ab low), it is preferable that the composition contains an acylphosphine oxide compound.
In order to improve the modeling accuracy of the three-dimensional object, the photopolymerization initiator is
It is preferable to include an acylphosphine oxide compound (e.g., 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide, bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide, etc.),
More preferably, it comprises 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide.
本開示の光硬化性組成物に含まれる光重合開始剤の量は、光重合性成分100質量部に対して0.1質量部~20質量部であることが好ましく、0.2質量部~10質量部であることがより好ましく、0.3質量部~5質量部であることが更に好ましく、0.3質量部~3質量部であることがさらに好ましい。 The amount of photopolymerization initiator contained in the photocurable composition of the present disclosure is preferably 0.1 parts by mass to 20 parts by mass, more preferably 0.2 parts by mass to 10 parts by mass, even more preferably 0.3 parts by mass to 5 parts by mass, and even more preferably 0.3 parts by mass to 3 parts by mass, per 100 parts by mass of the photopolymerizable component.
本開示の光硬化性組成物に含まれる(メタ)アクリルモノマー成分及び光重合開始剤の合計含有量は、光硬化性組成物全体の質量に対して、50質量%以上であることが好ましく、70質量%以上であることが好ましく、80質量%以上であることが好ましく、90質量%以上であることが好ましく、95質量%以上であることが好ましい。 The total content of the (meth)acrylic monomer component and the photopolymerization initiator contained in the photocurable composition of the present disclosure is preferably 50% by mass or more, more preferably 70% by mass or more, more preferably 80% by mass or more, more preferably 90% by mass or more, and more preferably 95% by mass or more, based on the total mass of the photocurable composition.
(フィラー)
本開示の光硬化性組成物は、更に、フィラーを少なくとも1種含有してもよい。
フィラーとしては、無機粒子が好ましく、無機酸化物粒子がより好ましい。
フィラーとしては、シリカ粒子(即ち、酸化ケイ素粒子)、ジルコニア粒子(即ち、酸化ジルコニウム粒子)、アルミノシリケート粒子、アルミナ粒子(即ち、酸化アルミニウム粒子)、及びチタニア粒子(即ち、酸化チタン粒子)からなる群から選択される少なくとも1種が更に好ましい。
フィラーは、シリカ粒子を含むことが特に好ましい。
(Filler)
The photocurable composition of the present disclosure may further contain at least one filler.
As the filler, inorganic particles are preferred, and inorganic oxide particles are more preferred.
The filler is more preferably at least one selected from the group consisting of silica particles (i.e., silicon oxide particles), zirconia particles (i.e., zirconium oxide particles), aluminosilicate particles, alumina particles (i.e., aluminum oxide particles), and titania particles (i.e., titanium oxide particles).
It is particularly preferred that the filler comprises silica particles.
フィラーの平均粒径は特に制限はないが、光照射による試験片A1の作製をより達成し易い観点から、好ましくは5nm~500nmであり、より好ましくは5nm~200nmであり、更に好ましくは5nm~100nmであり、更に好ましくは5nm~70nmである。
フィラーの平均粒径は、耐摩耗性が向上する観点から、40nm以上が好ましく、50nm以上がより好ましく、60nm以上がさらに好ましく、70nm以上が特に好ましい。
The average particle size of the filler is not particularly limited, but from the viewpoint of making it easier to achieve the production of test piece A1 by light irradiation, it is preferably 5 nm to 500 nm, more preferably 5 nm to 200 nm, even more preferably 5 nm to 100 nm, and even more preferably 5 nm to 70 nm.
From the viewpoint of improving abrasion resistance, the average particle size of the filler is preferably 40 nm or more, more preferably 50 nm or more, even more preferably 60 nm or more, and particularly preferably 70 nm or more.
本開示において、フィラーの平均粒径は、数平均一次粒子径を意味し、具体的には以下のようにして測定された値を意味する。
本開示の光硬化性組成物について光造形により硬化物(例えば、上述の試験片A1)を得た後、硬化物について断面を切り出す。得られた断面のTEM写真を撮影し、無作為に100個の粒径を選別し、これらの円相当径を求め、得られた円相当径を算術平均(数平均)する。
In the present disclosure, the average particle size of the filler means the number average primary particle size, and specifically means a value measured as follows.
After obtaining a cured product (e.g., the above-mentioned test piece A1) from the photocurable composition of the present disclosure by stereolithography, a cross section of the cured product is cut out, a TEM photograph of the cross section is taken, 100 particles are randomly selected, their circle-equivalent diameters are calculated, and the obtained circle-equivalent diameters are arithmetically averaged (number-averaged).
本開示の光硬化性組成物がフィラーを含有する場合、フィラーの含有量は、光重合性成分100質量部に対し、2質量部~100質量部であることが好ましく、5質量部~80質量部であることがより好ましく、5質量部~60質量部であることが更に好ましく、10質量部~50質量部であることが更に好ましい。 When the photocurable composition of the present disclosure contains a filler, the content of the filler is preferably 2 parts by mass to 100 parts by mass, more preferably 5 parts by mass to 80 parts by mass, even more preferably 5 parts by mass to 60 parts by mass, and even more preferably 10 parts by mass to 50 parts by mass, relative to 100 parts by mass of the photopolymerizable component.
フィラーは、目的に応じて、シランカップリング剤等の表面処理剤により表面処理が施されていてもよい。表面処理剤により、例えば、耐摩耗性等を、フィラーを含む光硬化性組成物の硬化物に付与することができる。
表面処理剤としては、特に限定されないが、例えば、シランカップリング剤を用いることができる。
シランカップリング剤としては、例えば、メタクリルオキシアルキルトリメトキシシラン(メタクリルオキシ基とケイ素原子との間の炭素数:3~12)、メタクリルオキシアルキルトリエトキシシラン(メタクリルオキシ基と珪素原子との間の炭素数:3~12)、ビニルトリメトキシシラン、ビニルエトキシシラン、ビニルトリアセトキシシラン等の有機珪素化合物が挙げられる。
Depending on the purpose, the filler may be surface-treated with a surface treatment agent such as a silane coupling agent. The surface treatment agent can impart, for example, abrasion resistance to a cured product of the photocurable composition containing the filler.
The surface treatment agent is not particularly limited, but for example, a silane coupling agent can be used.
Examples of the silane coupling agent include organic silicon compounds such as methacryloxyalkyltrimethoxysilane (number of carbon atoms between the methacryloxy group and the silicon atom: 3 to 12), methacryloxyalkyltriethoxysilane (number of carbon atoms between the methacryloxy group and the silicon atom: 3 to 12), vinyltrimethoxysilane, vinylethoxysilane, and vinyltriacetoxysilane.
(その他の成分)
本開示の光硬化性組成物は、必要に応じ、上述した成分以外のその他の成分を含んでいてもよい。
その他の成分としては、色材(顔料等)、改質剤、安定剤、酸化防止剤、溶剤、蛍光増白剤等が挙げられる。これらのその他の成分は、光硬化性組成物全体の質量に対して、各々の成分が(例えば、色材、安定剤、蛍光増白剤の各々が)0.0001質量%~0.1000質量%含まれていてもよい。
(Other ingredients)
The photocurable composition of the present disclosure may contain components other than the above-mentioned components, as necessary.
Examples of other components include color materials (pigments, etc.), modifiers, stabilizers, antioxidants, solvents, fluorescent brighteners, etc. Each of these other components (for example, each of the color materials, stabilizers, and fluorescent brighteners) may be contained in an amount of 0.0001% by mass to 0.1000% by mass relative to the total mass of the photocurable composition.
<粘度>
本開示の光硬化性組成物は、E型粘度計により25℃及び50rpmの条件で測定される粘度(以下、単に「粘度」ともいう)が、5mPa・s~6000mPa・sであることが好ましい。
ここで、rpmは、revolutions per minute(回転毎分)を意味する。
粘度が5mPa・s~6000mPa・sである場合には、光造形によって立体造形物を製造する際の光硬化性組成物の取り扱い性に優れる。
粘度は、10mPa・s~5000mPa・sであることがより好ましく、20mPa・s~4000mPa・sであることが更に好ましく、100mPa・s~3000mPa・sであることが更に好ましく、200mPa・s~2000mPa・sであることが更に好ましく、400mPa・s~1500mPa・sであることが更に好ましい。
<Viscosity>
The photocurable composition of the present disclosure preferably has a viscosity (hereinafter also simply referred to as "viscosity") measured with an E-type viscometer at 25°C and 50 rpm of 5 mPa·s to 6000 mPa·s.
Here, rpm means revolutions per minute.
When the viscosity is from 5 mPa·s to 6000 mPa·s, the photocurable composition has excellent handleability when a three-dimensional object is produced by stereolithography.
The viscosity is more preferably 10 mPa·s to 5000 mPa·s, even more preferably 20 mPa·s to 4000 mPa·s, even more preferably 100 mPa·s to 3000 mPa·s, even more preferably 200 mPa·s to 2000 mPa·s, and even more preferably 400 mPa·s to 1500 mPa·s.
<用途>
本開示の光硬化性組成物の用途には特に制限はない。
本開示の光硬化性組成物は、歯科用製品の製造に用いられる光硬化性組成物であることが好ましい。
歯科用製品としては、義歯(即ち人工歯)、義歯床、歯科用補綴物、口腔内で使用する医療器具、歯科用模型、消失鋳造用模型、等が挙げられる。
歯科用補綴物としては、インレー、クラウン、ブリッジ、テンポラリークラウン、テンポラリーブリッジ等が挙げられる。
口腔内で使用する医療器具としては、マウスピース、マウスガード、歯列矯正器具、スプリント(例えば咬合用スプリントなど)、印象採得用トレイ、手術用ガイド等が挙げられる。
歯科用模型としては、歯顎モデル等が挙げられる。
<Applications>
There are no particular limitations on the applications of the photocurable composition of the present disclosure.
The photocurable compositions of the present disclosure are preferably photocurable compositions used in the manufacture of dental products.
Examples of dental products include dentures (i.e., artificial teeth), denture bases, dental prostheses, medical instruments for use in the oral cavity, dental models, models for lost-loss casting, and the like.
Examples of dental prostheses include inlays, crowns, bridges, temporary crowns, and temporary bridges.
Examples of medical devices used in the oral cavity include mouthpieces, mouthguards, orthodontic appliances, splints (such as occlusal splints), impression trays, and surgical guides.
The dental model may include a tooth and jaw model.
〔立体造形物〕
本開示の立体造形物は、上述した本開示の光硬化性組成物の硬化物を含む。
本開示の光硬化性組成物は、好適には光造形用の光硬化性組成物として用いることができ、より好適には光造形によるスプリントの製造に用いられる。
[Three-dimensional objects]
The three-dimensional object of the present disclosure includes a cured product of the photocurable composition of the present disclosure described above.
The photocurable composition of the present disclosure can be suitably used as a photocurable composition for stereolithography, and more suitably used for producing splints by stereolithography.
〔歯科用製品〕
本開示の歯科用製品は、上述した本開示の立体造形物を含む。
歯科用製品の具体例は前述したとおりである。
歯科用製品としては、上述した本開示の立体造形物を含むスプリントが好ましい。
[Dental products]
The dental product of the present disclosure includes the three-dimensional object of the present disclosure described above.
Specific examples of dental products are described above.
As the dental product, a splint including the above-mentioned three-dimensionally shaped object of the present disclosure is preferable.
以下、本開示の実施例を示すが、本開示は以下の実施例には限定されない。
以下、各成分の詳細について説明する。
Examples of the present disclosure will be described below, but the present disclosure is not limited to the following examples.
Each component will be described in detail below.
<(メタ)アクリルモノマー(A)>
(メタ)アクリルモノマー(A)に分類される化合物は、具体的には下記光重合性成分1~10である。
光重合性成分1:ウレタンジアクリレートモノマー(Ebecryl8402、ダイセル・オルネクス株式会社、分子量1000)
光重合性成分2:ウレタンジアクリレートモノマー(Ebecryl8807、ダイセル・オルネクス株式会社、分子量1000)
光重合性成分3:ウレタンジアクリレートモノマー(Ebecryl230、ダイセル・オルネクス株式会社、分子量5000)
光重合性成分4:ウレタンジアクリレートモノマー(Ebecryl270、ダイセル・オルネクス株式会社、分子量2000)
光重合性成分5:ウレタンジアクリレートモノマー(UA-122P、新中村化学工業株式会社、分子量1100)
光重合性成分6:ウレタンジアクリレートモノマー(UA-160TM、新中村化学工業株式会社製、分子量1600)
光重合性成分7:ウレタンジアクリレートモノマー(UN-2700、根上工業株式会社、分子量2000)
光重合性成分8:ウレタンジアクリレートモノマー(UN-2600、根上工業株式会社、分子量2500)
光重合性成分9:ウレタンジアクリレートモノマー(UN-352、根上工業株式会社、分子量3000)
光重合性成分10:ウレタンジアクリレートモノマー(Genomer4230、Rahn AG、分子量9950)
<(Meth)acrylic monomer (A)>
Specific examples of compounds classified as the (meth)acrylic monomer (A) include the following photopolymerizable components 1 to 10.
Photopolymerizable component 1: urethane diacrylate monomer (Ebecryl 8402, Daicel Allnex Corporation, molecular weight 1000)
Photopolymerizable component 2: urethane diacrylate monomer (Ebecryl 8807, Daicel Allnex Corporation, molecular weight 1000)
Photopolymerizable component 3: urethane diacrylate monomer (Ebecryl 230, Daicel Allnex Corporation, molecular weight 5000)
Photopolymerizable component 4: urethane diacrylate monomer (Ebecryl 270, Daicel Allnex Corporation, molecular weight 2000)
Photopolymerizable component 5: urethane diacrylate monomer (UA-122P, Shin-Nakamura Chemical Co., Ltd., molecular weight 1100)
Photopolymerizable component 6: urethane diacrylate monomer (UA-160TM, manufactured by Shin-Nakamura Chemical Co., Ltd., molecular weight 1600)
Photopolymerizable component 7: urethane diacrylate monomer (UN-2700, Negami Chemical Industries, Ltd., molecular weight 2000)
Photopolymerizable component 8: urethane diacrylate monomer (UN-2600, Negami Chemical Industries, Ltd., molecular weight 2500)
Photopolymerizable component 9: urethane diacrylate monomer (UN-352, Negami Chemical Industries, Ltd., molecular weight 3000)
Photopolymerizable component 10: urethane diacrylate monomer (Genomer 4230, Rahn AG, molecular weight 9950)
<(メタ)アクリルモノマー(B)>
(メタ)アクリルモノマー(B)に分類される化合物は、具体的には下記光重合性成分11~20である。
<(Meth)acrylic monomer (B)>
Specific examples of compounds classified as the (meth)acrylic monomer (B) include the following photopolymerizable components 11 to 20.
光重合性成分11:エトキシ化ビスフェノールAジアクリレート(ABE-300、新中村化学工業株式会社、分子量469)
光重合性成分12:エトキシ化ビスフェノールAジアクリレート(A-BPE-4、新中村化学工業株式会社、分子量513)
光重合性成分13:エトキシ化ビスフェノールAジメタクリレート(SR540、サートマー株式会社、分子量541)
光重合性成分14:ウレタンジアクリレート(UDA、下記製造例1に従って製造した化合物、分子量443)
光重合性成分15:ウレタンジメタクリレート(UDMA、富士フイルム和光純薬株式会社、分子量471)
光重合性成分16:2官能ウレタンアクリレート(AH-600、共栄社化学株式会社、分子量613)
光重合性成分17:テトラエチレングリコールジアクリレート(4EG-A、共栄社化学株式会社、分子量302)
光重合性成分18:ノナンプロピレングリコールジメタクリレート(9PG、共栄社化学株式会社、分子量561)
光重合性成分19:2官能ウレタンアクリレート(PUDA-1、分子量633)
光重合性成分20:プロポキシレートネオペンチルグリコールジアクリレート(SR9003NS、アルケマ株式会社、分子量328)
Photopolymerizable component 11: ethoxylated bisphenol A diacrylate (ABE-300, Shin-Nakamura Chemical Co., Ltd., molecular weight 469)
Photopolymerizable component 12: ethoxylated bisphenol A diacrylate (A-BPE-4, Shin-Nakamura Chemical Co., Ltd., molecular weight 513)
Photopolymerizable component 13: ethoxylated bisphenol A dimethacrylate (SR540, Sartomer Corporation, molecular weight 541)
Photopolymerizable component 14: urethane diacrylate (UDA, compound produced according to Production Example 1 below, molecular weight 443)
Photopolymerizable component 15: urethane dimethacrylate (UDMA, Fujifilm Wako Pure Chemical Industries, molecular weight 471)
Photopolymerizable component 16: Bifunctional urethane acrylate (AH-600, Kyoeisha Chemical Co., Ltd., molecular weight 613)
Photopolymerizable component 17: Tetraethylene glycol diacrylate (4EG-A, Kyoeisha Chemical Co., Ltd., molecular weight 302)
Photopolymerizable component 18: Nonanepropylene glycol dimethacrylate (9PG, Kyoeisha Chemical Co., Ltd., molecular weight 561)
Photopolymerizable component 19: Bifunctional urethane acrylate (PUDA-1, molecular weight 633)
Photopolymerizable component 20: Propoxylated neopentyl glycol diacrylate (SR9003NS, Arkema Co., Ltd., molecular weight 328)
<(メタ)アクリルモノマー(C)>
表1~表5中、(メタ)アクリルモノマー(C)に分類される化合物は、具体的には下記光重合性成分21~26である。
<(Meth)acrylic monomer (C)>
In Tables 1 to 5, the compounds classified as the (meth)acrylic monomer (C) are specifically the following photopolymerizable components 21 to 26.
光重合性成分21:ベンジルメタクリレート(BZ、共栄社化学株式会社、分子量176)
光重合性成分22:フェノキシエチルメタクリレート(PO、共栄社化学株式会社、分子量206)
光重合性成分23:フェノキシエチルアクリレート(PO-A、共栄社化学株式会社、分子量192)
光重合性成分24:m-フェノキシベンジルアクリレート(POB-A、共栄社化学株式会社、分子量254)
光重合性成分25:2-(o-フェニルフェノキシ)エチルアクリレート(HRD-01、日触テクノファインケミカル株式会社、分子量268)
光重合性成分26:2-ヒドロキシ-3-フェノキシプロピルアクリレート(M600-A、共栄社化学株式会社、分子量222)
Photopolymerizable component 21: benzyl methacrylate (BZ, Kyoeisha Chemical Co., Ltd., molecular weight 176)
Photopolymerizable component 22: Phenoxyethyl methacrylate (PO, Kyoeisha Chemical Co., Ltd., molecular weight 206)
Photopolymerizable component 23: Phenoxyethyl acrylate (PO-A, Kyoeisha Chemical Co., Ltd., molecular weight 192)
Photopolymerizable component 24: m-phenoxybenzyl acrylate (POB-A, Kyoeisha Chemical Co., Ltd., molecular weight 254)
Photopolymerizable component 25: 2-(o-phenylphenoxy)ethyl acrylate (HRD-01, Nisshoku Techno Fine Chemical Co., Ltd., molecular weight 268)
Photopolymerizable component 26: 2-hydroxy-3-phenoxypropyl acrylate (M600-A, Kyoeisha Chemical Co., Ltd., molecular weight 222)
<(メタ)アクリルモノマー(D)>
表1~表5中、(メタ)アクリルモノマー(D)に分類される化合物は、具体的には下記光重合性成分27~31である。
<(Meth)acrylic monomer (D)>
In Tables 1 to 5, the compounds classified as the (meth)acrylic monomer (D) are specifically the following photopolymerizable components 27 to 31.
光重合性成分27:ターシャリーブチルメタクリレート(TB、共栄社化学株式会社、分子量142)
光重合性成分28:シクロヘキシルメタクリレート(CH、共栄社化学株式会社、分子量168)
光重合性成分29:イソボルニルメタクリレート(IBX、共栄社化学株式会社、分子量222)
光重合性成分30:イソボルニルアクリレート(IBXA、共栄社化学株式会社、分子量208)
光重合性成分31:テトラヒドロフルフリルメタクリレート(THF(1000)、共栄社化学株式会社、分子量170)
Photopolymerizable component 27: tertiary butyl methacrylate (TB, Kyoeisha Chemical Co., Ltd., molecular weight 142)
Photopolymerizable component 28: cyclohexyl methacrylate (CH, Kyoeisha Chemical Co., Ltd., molecular weight 168)
Photopolymerizable component 29: Isobornyl methacrylate (IBX, Kyoeisha Chemical Co., Ltd., molecular weight 222)
Photopolymerizable component 30: Isobornyl acrylate (IBXA, Kyoeisha Chemical Co., Ltd., molecular weight 208)
Photopolymerizable component 31: Tetrahydrofurfuryl methacrylate (THF (1000), Kyoeisha Chemical Co., Ltd., molecular weight 170)
<光重合開始剤>
光重合開始剤に分類される化合物は、具体的には下記光重合開始剤1及び2である。
<Photopolymerization initiator>
Specific examples of compounds classified as photopolymerization initiators include photopolymerization initiators 1 and 2 shown below.
光重合開始剤1:アシルフォスフィンオキサイド系化合物(Omnirad TPO:IGM Resins B.V.社製「Omnirad TPO」)
光重合開始剤2:アシルフォスフィンオキサイド系化合物(Omnirad 819:IGM Resins B.V.社製「Omnirad 819」)
Photopolymerization initiator 1: acylphosphine oxide compound (Omnirad TPO: "Omnirad TPO" manufactured by IGM Resins B.V.)
Photopolymerization initiator 2: acylphosphine oxide compound (Omnirad 819: "Omnirad 819" manufactured by IGM Resins B.V.)
(製造例1:UDAの製造)
十分に乾燥させた撹拌羽根、及び温度計を備えた1リットル4ツ口フラスコ内に、HEA372g(3.20モル)、DBTDL0.71g(HEAとTMHDIの合計質量に対して0.1質量%)、及びMEHQ0.35g(HEAとTMHDIの合計質量に対して0.05質量%)を添加し、均一となるまで撹拌した後、60℃に昇温した。続いて、TMHDI337g(1.60モル)を1時間かけて滴下した。滴下中に反応熱により内温が上昇したので、80℃以下となるように滴下量をコントロールした。全量滴下後反応温度を80℃に保って、10時間反応を行った。この際、HPLC分析で反応の進行を追跡して、反応の終点を確認した。反応器から生成物を排出することにより、2官能ウレタンアクリレート(UDA)680gを得た。25℃における粘度は7100mPa・sであった。
(Production Example 1: Production of UDA)
In a 1-liter four-neck flask equipped with a thoroughly dried stirring blade and a thermometer, 372 g (3.20 mol) of HEA, 0.71 g of DBTDL (0.1% by mass relative to the total mass of HEA and TMHDI), and 0.35 g of MEHQ (0.05% by mass relative to the total mass of HEA and TMHDI) were added, stirred until uniform, and then heated to 60 ° C. Then, 337 g (1.60 mol) of TMHDI was dropped over 1 hour. During the drop, the internal temperature rose due to the reaction heat, so the amount of drop was controlled so that it was 80 ° C. or less. After the entire amount was dropped, the reaction temperature was kept at 80 ° C. and the reaction was carried out for 10 hours. At this time, the progress of the reaction was tracked by HPLC analysis to confirm the end point of the reaction. By discharging the product from the reactor, 680 g of bifunctional urethane acrylate (UDA) was obtained. The viscosity at 25 ° C. was 7100 mPa · s.
(製造例2:PUDA-1の製造)
撹拌羽根、及び温度計を備えたフラスコ内に、アロニックス M-5700(東亞合成)44.4g(0.20モル)、DBTDL0.063g、及びMEHQ0.032gを添加し、均一となるまで撹拌した後、60℃に昇温した。続いて、XDI18.8g(0.10モル)を80℃以下となるように滴下量をコントロールした。全量滴下後反応温度を80℃に保って、3時間反応を行った。この際、HPLC分析で反応の進行を追跡して、反応の終点を確認した。反応器から生成物を排出することにより、ウレタンジアクリレート(PUDA-1)63gを得た。65℃における粘度は3520mPa・sであった。
(Production Example 2: Production of PUDA-1)
In a flask equipped with a stirring blade and a thermometer, 44.4 g (0.20 mol) of Aronix M-5700 (Toagosei), 0.063 g of DBTDL, and 0.032 g of MEHQ were added, stirred until homogeneous, and then heated to 60°C. Next, 18.8 g (0.10 mol) of XDI was added dropwise, controlling the amount so that the temperature was 80°C or less. After the entire amount was added dropwise, the reaction temperature was kept at 80°C and the reaction was carried out for 3 hours. At this time, the progress of the reaction was tracked by HPLC analysis to confirm the end point of the reaction. By discharging the product from the reactor, 63 g of urethane diacrylate (PUDA-1) was obtained. The viscosity at 65°C was 3520 mPa·s.
本開示の実施例に使用した化合物の略号を以下に示す。
HEA:ヒドロキシエチルアクリレート
DBTDL:ジブチルスズジラウレート
MEHQ:4-メトキシフェノール
TMHDI:2,2,4-トリメチルヘキサメチレンジイソシアネートと2,4,4-トリメチルヘキサメチレンジイソシアネートとの混合物
XDI:m-キシリレンジイソシアネート
The abbreviations for the compounds used in the examples of the present disclosure are shown below.
HEA: Hydroxyethyl acrylate DBTDL: Dibutyltin dilaurate MEHQ: 4-Methoxyphenol TMHDI: Mixture of 2,2,4-trimethylhexamethylene diisocyanate and 2,4,4-trimethylhexamethylene diisocyanate XDI: m-Xylylene diisocyanate
<光硬化性組成物の調製>
表1~表5に示す材料を用いて光硬化性組成物を調製した。
表1~表5に示すΔE*
abの値は、透明PMMA板(旭製作所、L*=96.98、a*=-0.24、b*=0.05)との色差を示す。
表1~表5に示す実施例は全てE型粘度計(東機産業株式会社製、TVE-35H)により25℃及び50rpmの条件で測定される粘度が、5mPa・s~6000mPa・sであった。
<Preparation of Photocurable Composition>
Photocurable compositions were prepared using the materials shown in Tables 1 to 5.
The ΔE * ab values shown in Tables 1 to 5 indicate the color difference from a transparent PMMA plate (Asahi Manufacturing, L * =96.98, a * =−0.24, b * =0.05).
The viscosities of all of the examples shown in Tables 1 to 5, measured using an E-type viscometer (TVE-35H, manufactured by Toki Sangyo Co., Ltd.) at 25° C. and 50 rpm, were 5 mPa·s to 6000 mPa·s.
<メタクリロイル基含有率>
比較例と実施例で調製した光硬化性組成物のメタクリロイル基含有率は、組成物中のアクリロイル基とメタクリロイル基の合計含有量(mol/g)に対する、メタクリロイル基の含有量(mol/g)の比率である。結果を表1~表5に示す。
<Methacryloyl Group Content>
The methacryloyl group content of the photocurable compositions prepared in the Comparative Examples and Examples is the ratio of the methacryloyl group content (mol/g) to the total content (mol/g) of the acryloyl group and the methacryloyl group in the composition. The results are shown in Tables 1 to 5.
<37℃での貯蔵弾性率の測定>
比較例と実施例で調製した光硬化性組成物を用いて得られた硬化物の37℃での貯蔵弾性率を下記の方法により測定した。結果を表1~表5に示す。
3Dプリンタ(Kulzer社、Cara Print4.0PRO)を用い、測定対象の光硬化性組成物を用いて長さ40mm、幅10mm、厚さ1mmの試験片を、積層幅50μmとし、各層に波長385nmの可視光を11mJ/cm2照射する条件で造形する。得られた試験片に対し、波長365nmの紫外線を10J/cm2の条件で照射して光硬化性組成物を本硬化させることにより、試験片A1の硬化物を得る。
得られた試験片A1の硬化物を、動的粘弾性測定装置(アイティー計測制御製、DVA-225)にて、25℃~100℃まで3℃/minの速度で昇温しながら、測定周波数1Hzで貯蔵弾性率を測定し、37℃における貯蔵弾性率を読み取る。
<Measurement of storage modulus at 37° C.>
The storage modulus at 37° C. of the cured products obtained using the photocurable compositions prepared in the Comparative Examples and Examples was measured by the following method. The results are shown in Tables 1 to 5.
Using a 3D printer (Kulzer, Cara Print 4.0 PRO), a test piece 40 mm long, 10 mm wide, and 1 mm thick is produced using the photocurable composition to be measured, with a layer width of 50 μm, and each layer is irradiated with visible light having a wavelength of 385 nm at 11 mJ/cm 2. The obtained test piece is irradiated with ultraviolet light having a wavelength of 365 nm at 10 J/cm 2 to fully cure the photocurable composition, thereby obtaining a cured product of test piece A1.
The storage modulus of the obtained cured test piece A1 is measured at a frequency of 1 Hz while heating the test piece from 25°C to 100°C at a rate of 3°C/min using a dynamic viscoelasticity measuring device (DVA-225, manufactured by IT Measurement & Control Co., Ltd.), and the storage modulus at 37°C is read.
<ΔE*
abの測定>
比較例と実施例で調製した光硬化性組成物を用いて得られた硬化物のΔE*
abを下記の方法により測定した。結果を表1~表5に示す。
3Dプリンタ(Kulzer社、Cara Print4.0PRO)を用い、測定対象の光硬化性組成物を用いて50mm×40mm×4.5mmの試験片を、積層幅50μmとし、各層に波長385nmの可視光を11mJ/cm2照射する条件で造形する。得られた試験片に対し、波長365nmの紫外線を10J/cm2の条件で照射して光硬化性組成物を本硬化させることにより、試験片の硬化物を得る。得られた試験片の硬化物を、回転研磨機(ビューラー社製、エコメット30)にて、150rpmで、50mm×40mmの面を両面、400番の研磨紙にて片面0.15mm、800番の研磨紙にて片面0.07mm、1000番の研磨紙にて片面0.02mm、2000番の研磨紙にて片面0.01mm、合計0.25mmずつ研磨し、Polishing Cloth (ビューラー社製、MasterTex Polishing Cloth 40-7742)と研磨剤(株式会社三啓製、高純度アルミナパウダー、粒径1μm)1gを用いて、片面15秒研磨し、50mm×40mm×4.0mmの研磨済み試験片A2を得る。
色差計(日本電色工業株式会社製、SD3000)にて、50mm×40mmの面のL*a*b*を透過モードによって、付属のSTANDARD WHITE PLATE(SCI X:94.25、Y:99.44、Z:106.37)をリファレンスとして測定する。50mm×40mm×4.0mmの透明PMMA板(株式会社旭製作所製、L*=96.98、a*=-0.24、b*=0.05;「SCI X:94.25、Y:99.44、Z:106.37」をリファレンスとする色の数値)のL*a*b*を基準色として、ΔE*
ab=(ΔL2+Δa2+Δb2)1/2の計算式にて、ΔE*
abを算出する。
<Measurement of ΔE * ab >
The ΔE * ab of the cured products obtained using the photocurable compositions prepared in the Comparative Examples and Examples was measured by the following method. The results are shown in Tables 1 to 5.
Using a 3D printer (Kulzer, Cara Print 4.0 PRO), a test piece of 50 mm x 40 mm x 4.5 mm is produced using the photocurable composition to be measured, with a layer width of 50 μm, and each layer is irradiated with visible light of 385 nm wavelength at 11 mJ/cm 2. The obtained test piece is irradiated with ultraviolet light of 365 nm wavelength at 10 J/cm 2 to fully cure the photocurable composition, thereby obtaining a cured product of the test piece. The obtained cured test piece was polished on both sides of 50 mm x 40 mm with a rotary polisher (Ecomet 30, manufactured by Buehler) at 150 rpm, 0.15 mm on one side with 400-number abrasive paper, 0.07 mm on one side with 800-number abrasive paper, 0.02 mm on one side with 1000-number abrasive paper, and 0.01 mm on one side with 2000-number abrasive paper, for a total of 0.25 mm, and polished for 15 seconds on each side using Polishing Cloth (MasterTex Polishing Cloth 40-7742, manufactured by Buehler) and 1 g of an abrasive (high-purity alumina powder, particle size 1 μm, manufactured by Sankei Co., Ltd.) to obtain a polished test piece A2 of 50 mm x 40 mm x 4.0 mm.
Using a color difference meter (SD3000, manufactured by Nippon Denshoku Industries Co., Ltd.), measure the L * a * b * of a 50 mm x 40 mm surface in transmission mode using the attached STANDARD WHITE PLATE (SCI X: 94.25, Y: 99.44, Z: 106.37) as a reference. Calculate ΔE*ab using the formula ΔE*ab = (ΔL2 + Δa2 + Δb2) 1/2, using the L * a * b * of a 50 mm x 40 mm x 4.0 mm transparent PMMA plate ( manufactured by Asahi Seisakusho Co., Ltd., L* = 96.98, a* = -0.24, b* = 0.05; color values based on "SCI X : 94.25 , Y : 99.44, Z: 106.37" as a reference color).
<385nmプリンタでの造形性の評価>
3Dプリンタ(Kulzer社製、Cara Print4.0)を用い、測定対象の光硬化性組成物を用いて、50mm×40mm×4.5mmの試験片を、積層幅50μmとし、各層に波長385nmの可視光を11mJ/cm2照射する条件で造形し、造形物に対し、波長365nmの紫外線を照射量10J/cm2照射することで、試験片A3を得る。試験片A3の表面状態を、以下の基準で評価する。結果を表1~表5に示す。
3:造形した試験片A1、A2の表面状態が滑沢であり、べとつきがない。
2:造形した試験片A1、A2の表面状態がべとつきはないが、滑沢でない。
1:造形した試験片A1、A2の表面状態はべとつきがありかつ滑沢でないか、又は試験片が得られない。
上記試験片が得られないとは、例えば硬化しない又はゲル状態のものしか得られない状態である。
<Evaluation of modeling properties using a 385 nm printer>
Using a 3D printer (Kulzer, Cara Print 4.0), a test piece of 50 mm x 40 mm x 4.5 mm is formed using the photocurable composition to be measured under conditions of a laminate width of 50 μm and irradiating each layer with visible light of a wavelength of 385 nm at 11 mJ/cm 2 , and then irradiating the formed object with ultraviolet light of a wavelength of 365 nm at an irradiation dose of 10 J/cm 2 to obtain test piece A3. The surface condition of test piece A3 is evaluated according to the following criteria. The results are shown in Tables 1 to 5.
3: The surface condition of the shaped test pieces A1 and A2 is smooth and not sticky.
2: The surface condition of the shaped test pieces A1 and A2 is not sticky, but is not smooth.
1: The surface condition of the shaped test pieces A1 and A2 is sticky and not smooth, or no test pieces can be obtained.
The inability to obtain the test piece refers to, for example, a state in which only a non-cured or gel-like specimen is obtained.
表1~表5に示すように、光重合性成分と、光重合開始剤とを含有する光硬化性組成物であって、光硬化性組成物に対し波長385nmの可視光を照射量11mJ/cm2にて照射して厚さ50μmの硬化層A1を形成し、硬化層A1を厚さ方向に積層させることにより、長さ40mm、幅10mm、厚さ1mmの矩形板形状の造形物A1を形成し、造形物A1に対し、波長365nmの紫外線を照射量10J/cm2照射することにより、長さ40mm、幅10mm、厚さ1mmの矩形板形状の試験片A1を作製した場合に、試験片A1の37℃での貯蔵弾性率が100MPa以上1500MPa以下である光硬化性組成物を用いた実施例は、機械強度を維持した状態で高い透明性を確保することができた。
また、実施例に係る光硬化性組成物を用いて得られる造形物は、機械強度と柔らかさのバランスに優れるため、歯軋り等に対して摩耗しにくく、かつ、口腔内装着される際の装着者の負担が軽減されると推測される。
As shown in Tables 1 to 5, a photocurable composition containing a photopolymerizable component and a photopolymerization initiator was irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/cm 2 to form a cured layer A1 having a thickness of 50 μm, and the cured layer A1 was laminated in the thickness direction to form a rectangular plate-shaped object A1 having a length of 40 mm, a width of 10 mm, and a thickness of 1 mm. The object A1 was irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/cm 2 to produce a rectangular plate-shaped test piece A1 having a length of 40 mm, a width of 10 mm, and a thickness of 1 mm. In the examples using the photocurable composition, the storage modulus of the test piece A1 at 37 ° C. was 100 MPa or more and 1500 MPa or less, and high transparency could be ensured while maintaining mechanical strength.
In addition, since the object obtained using the photocurable composition of the examples has an excellent balance between mechanical strength and softness, it is presumed that it is less susceptible to wear due to teeth grinding, etc., and that the burden on the wearer when worn in the oral cavity is reduced.
2022年11月29日に出願された日本出願特願2022-190496の開示は、その全体が参照により本明細書に取り込まれる。
本明細書に記載された全ての文献、特許出願、及び技術規格は、個々の文献、特許出願、及び技術規格が参照により取り込まれることが具体的かつ個々に記された場合と同程度に、本明細書中に参照により取り込まれる。
The disclosure of Japanese Patent Application No. 2022-190496, filed on November 29, 2022, is incorporated herein by reference in its entirety.
All publications, patent applications, and standards mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent application, or standard was specifically and individually indicated to be incorporated by reference.
Claims (19)
前記光硬化性組成物に対し波長385nmの可視光を照射量11mJ/cm2にて照射して厚さ50μmの硬化層A1を形成し、前記硬化層A1を厚さ方向に積層させることにより、長さ40mm、幅10mm、厚さ1mmの矩形板形状の造形物A1を形成し、前記造形物A1に対し、波長365nmの紫外線を照射量10J/cm2照射することにより、長さ40mm、幅10mm、厚さ1mmの矩形板形状の試験片A1を作製した場合に、前記試験片A1の37℃での貯蔵弾性率が100MPa以上1500MPa以下である光硬化性組成物。 A photocurable composition comprising a photopolymerizable component and a photopolymerization initiator,
The photocurable composition is irradiated with visible light having a wavelength of 385 nm at an irradiation dose of 11 mJ/ cm2 to form a cured layer A1 with a thickness of 50 μm, and the cured layer A1 is laminated in the thickness direction to form a rectangular plate-shaped object A1 with a length of 40 mm, a width of 10 mm and a thickness of 1 mm. The object A1 is irradiated with ultraviolet light having a wavelength of 365 nm at an irradiation dose of 10 J/ cm2 to produce a rectangular plate-shaped test piece A1 with a length of 40 mm, a width of 10 mm and a thickness of 1 mm. The photocurable composition has a storage modulus at 37° C. of 100 MPa or more and 1500 MPa or less.
2つの(メタ)アクリロイルオキシ基を含み、分子量が1000以上である(メタ)アクリルモノマー(A)と、
2つの(メタ)アクリロイルオキシ基を含み、分子量が170以上1000未満である(メタ)アクリルモノマー(B)と、
1つの(メタ)アクリロイルオキシ基を含み、芳香環構造を含む(メタ)アクリルモノマー(C)と、
を含む請求項1に記載の光硬化性組成物。 The photopolymerizable component is
A (meth)acrylic monomer (A) containing two (meth)acryloyloxy groups and having a molecular weight of 1000 or more;
a (meth)acrylic monomer (B) containing two (meth)acryloyloxy groups and having a molecular weight of 170 or more and less than 1,000;
A (meth)acrylic monomer (C) containing one (meth)acryloyloxy group and containing an aromatic ring structure;
The photocurable composition of claim 1 comprising:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024561551A JPWO2024117203A1 (en) | 2022-11-29 | 2023-11-29 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022190496 | 2022-11-29 | ||
| JP2022-190496 | 2022-11-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2024117203A1 true WO2024117203A1 (en) | 2024-06-06 |
Family
ID=91323929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2023/042813 Ceased WO2024117203A1 (en) | 2022-11-29 | 2023-11-29 | Photocurable composition, three-dimensional shaped article, dental product, and splint |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2024117203A1 (en) |
| WO (1) | WO2024117203A1 (en) |
Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070066704A1 (en) * | 2003-10-06 | 2007-03-22 | Basf Aktiengesellschaft | Radiation-hardenable coating agent containing aliphatic urethane (meth) acrylate |
| KR20090090866A (en) * | 2008-02-22 | 2009-08-26 | 윤중호 | High refractive, high elastic prism sheet, composition for the same and manufacturing method thereof |
| JP2011225878A (en) * | 2010-04-22 | 2011-11-10 | Xerox Corp | Curable composition for three-dimensional printing |
| JP2013064126A (en) * | 2011-08-31 | 2013-04-11 | Sanyo Chem Ind Ltd | Active energy ray-curable resin composition |
| WO2015141537A1 (en) * | 2014-03-17 | 2015-09-24 | Kjケミカルズ株式会社 | Urethane oligomer and active energy ray curable resin composition containing same |
| JP2016112823A (en) * | 2014-12-17 | 2016-06-23 | コニカミノルタ株式会社 | Method for manufacturing 3d molded object, model material ink and ink set |
| JP2017025124A (en) * | 2015-07-15 | 2017-02-02 | 株式会社リコー | Active-energy-ray-curable composition |
| WO2018105463A1 (en) * | 2016-12-05 | 2018-06-14 | Dic株式会社 | Photocurable resin composition for optical stereolithography |
| JP2019521188A (en) * | 2016-06-20 | 2019-07-25 | デンツプライ シロナ インコーポレイテッド | Three-dimensional shaped material system and method for producing layered dental products |
| WO2019189566A1 (en) * | 2018-03-28 | 2019-10-03 | クラレノリタケデンタル株式会社 | Photocurable resin composition |
| JP2020536142A (en) * | 2017-10-02 | 2020-12-10 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | UV curable compositions, methods, and articles obtained from them with controlled mechanical and chemical properties. |
| JP2021504511A (en) * | 2017-11-22 | 2021-02-15 | スリーエム イノベイティブ プロパティズ カンパニー | Photopolymerizable compositions, articles, and methods comprising urethane components and monofunctional reactive diluents. |
| WO2021162007A1 (en) * | 2020-02-10 | 2021-08-19 | クラレノリタケデンタル株式会社 | Resin composition for stereolithography |
-
2023
- 2023-11-29 WO PCT/JP2023/042813 patent/WO2024117203A1/en not_active Ceased
- 2023-11-29 JP JP2024561551A patent/JPWO2024117203A1/ja active Pending
Patent Citations (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070066704A1 (en) * | 2003-10-06 | 2007-03-22 | Basf Aktiengesellschaft | Radiation-hardenable coating agent containing aliphatic urethane (meth) acrylate |
| KR20090090866A (en) * | 2008-02-22 | 2009-08-26 | 윤중호 | High refractive, high elastic prism sheet, composition for the same and manufacturing method thereof |
| JP2011225878A (en) * | 2010-04-22 | 2011-11-10 | Xerox Corp | Curable composition for three-dimensional printing |
| JP2013064126A (en) * | 2011-08-31 | 2013-04-11 | Sanyo Chem Ind Ltd | Active energy ray-curable resin composition |
| WO2015141537A1 (en) * | 2014-03-17 | 2015-09-24 | Kjケミカルズ株式会社 | Urethane oligomer and active energy ray curable resin composition containing same |
| JP2016112823A (en) * | 2014-12-17 | 2016-06-23 | コニカミノルタ株式会社 | Method for manufacturing 3d molded object, model material ink and ink set |
| JP2017025124A (en) * | 2015-07-15 | 2017-02-02 | 株式会社リコー | Active-energy-ray-curable composition |
| JP2019521188A (en) * | 2016-06-20 | 2019-07-25 | デンツプライ シロナ インコーポレイテッド | Three-dimensional shaped material system and method for producing layered dental products |
| WO2018105463A1 (en) * | 2016-12-05 | 2018-06-14 | Dic株式会社 | Photocurable resin composition for optical stereolithography |
| JP2020536142A (en) * | 2017-10-02 | 2020-12-10 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | UV curable compositions, methods, and articles obtained from them with controlled mechanical and chemical properties. |
| JP2021504511A (en) * | 2017-11-22 | 2021-02-15 | スリーエム イノベイティブ プロパティズ カンパニー | Photopolymerizable compositions, articles, and methods comprising urethane components and monofunctional reactive diluents. |
| WO2019189566A1 (en) * | 2018-03-28 | 2019-10-03 | クラレノリタケデンタル株式会社 | Photocurable resin composition |
| WO2021162007A1 (en) * | 2020-02-10 | 2021-08-19 | クラレノリタケデンタル株式会社 | Resin composition for stereolithography |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2024117203A1 (en) | 2024-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110785158B (en) | Curable composition for preparing dental composite crowns and method of preparation | |
| ES3023519T3 (en) | Transparent, fracture-resistant polymerisation resins for the production of dental mouldings | |
| US12240929B2 (en) | Photocurable composition, denture base, and plate denture | |
| JP7662512B2 (en) | Photocurable composition, cured product, and dental product | |
| WO2018025943A1 (en) | Photocurable composition, denture base, and removable denture | |
| WO2016125758A1 (en) | Light-curable composition, denture, and plate denture | |
| KR101517628B1 (en) | Materials for deriving improved dental composites and dental composites made therefrom | |
| WO2023190071A1 (en) | Photosetting composition, three-dimensionally shaped article, mold, method for manufacturing cured product, and method for manufacturing plate denture | |
| CN111093594A (en) | Dental curable composition | |
| JP7412535B2 (en) | Photocurable compositions, cured products, and dental products | |
| WO2024117203A1 (en) | Photocurable composition, three-dimensional shaped article, dental product, and splint | |
| JP2023143923A (en) | Photocurable compositions and dental products | |
| JP7429783B2 (en) | Photocurable compositions, three-dimensional objects, and dental products | |
| JP7326590B2 (en) | Photocurable composition, three-dimensional object, and dental product | |
| JP2024068663A (en) | Dental material for producing full or partial dental prostheses | |
| US20250002631A1 (en) | Radically Polymerizable Materials For The Production Of Dental Molding With Little Discoloration | |
| WO2023189684A1 (en) | Photocurable composition, three-dimensional molded article, dental product, and splint | |
| JP2024129743A (en) | Photocurable composition, three-dimensional object, and dental product | |
| JP2023146821A (en) | Curable composition for optically molding, dental product, and denture base | |
| US20250215129A1 (en) | Photocurable composition, three-dimensional modeling product, and dental product | |
| US20250009608A1 (en) | Radically Polymerizable Materials For The Production Of Dental Moldings With High Fracture Toughness | |
| WO2025009596A1 (en) | Photocurable composition, three-dimensional shaped object, casting mold, method for producing cured object, and method for producing dental prosthesis | |
| JP2025045906A (en) | Method for manufacturing equipment, photocurable composition, three-dimensional object and mold | |
| JP2022135159A (en) | Curable composition for stereolithography, and dental product | |
| WO2023189780A1 (en) | Photocurable composition, three-dimensional shaped object, and tool to be fit inside oral cavity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23897849 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2024561551 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 23897849 Country of ref document: EP Kind code of ref document: A1 |